Skip to main content

Advertisement

SpringerLink
Log in

Nanotechnology: Intelligent Design to Treat Complex Disease

  • Expert Review
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

The purpose of this expert review is to discuss the impact of nanotechnology in the treatment of the major health threats including cancer, infections, metabolic diseases, autoimmune diseases, and inflammations. Indeed, during the past 30 years, the explosive growth of nanotechnology has burst into challenging innovations in pharmacology, the main input being the ability to perform temporal and spatial site-specific delivery. This has led to some marketed compounds through the last decade. Although the introduction of nanotechnology obviously permitted to step over numerous milestones toward the development of the “magic bullet” proposed a century ago by the immunologist Paul Ehrlich, there are, however, unresolved delivery problems to be still addressed. These scientific and technological locks are discussed along this review together with an analysis of the current situation concerning the industrial development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. G. Gregoriadis E. J. Wills C. P. Swain A. S. Tavill (1974) ArticleTitleDrug carrier potential of liposomes in cancer chemotherapy Lancet 1 1313–1316 Occurrence Handle4134296 Occurrence Handle1:STN:280:DyaE2c3lt12lsg%3D%3D Occurrence Handle10.1016/S0140-6736(74)90682-5

    Article  PubMed  CAS  Google Scholar 

  2. C. Hu D. G. Rhodes (2000) ArticleTitleProniosomes: a novel drug carrier preparation Int. J. Pharm. 206 110–122 Occurrence Handle11202988 Occurrence Handle1:STN:280:DC%2BD3M%2FjtVKqsA%3D%3D Occurrence Handle10.1016/S0378-5173(00)00513-5

    Article  PubMed  CAS  Google Scholar 

  3. K. K. Jain (2005) ArticleTitleThe role of nanobiotechnology in drug discovery Drug Discov. Today 10 1435–1442 Occurrence Handle16243263 Occurrence Handle1:CAS:528:DC%2BD2MXhtFers7rL Occurrence Handle10.1016/S1359-6446(05)03573-7

    Article  PubMed  CAS  Google Scholar 

  4. J. K. Vasir M. K. Maram V. D. Labhasetwar (2005) ArticleTitleNanosystems in drug targeting: opportunities and challenges Curr. Nanosci. 1 47–67 Occurrence Handle1:CAS:528:DC%2BD2MXit1aktb4%3D Occurrence Handle10.2174/1573413052953110

    Article  CAS  Google Scholar 

  5. A. Bianco J. Hoebeke S. Godefroy O. Chaloin D. Pantarotto J. P. Briand S. Muller M. Prati C. D. Partidos (2005) ArticleTitleCationic carbon nanotubes bind to CpG oligodeoxynucleotides and enhance their immunostimulatory properties J. Am. Chem. Soc. 127 58–59 Occurrence Handle15631447 Occurrence Handle1:CAS:528:DC%2BD2cXhtVyltrvO Occurrence Handle10.1021/ja044293y

    Article  PubMed  CAS  Google Scholar 

  6. A. Bianco K. Costarelos M. Prato (2005) ArticleTitleApplications of carbon nanotubes in drug delivery Curr. Opin. Chem. Biol. 9 674–679 Occurrence Handle16233988 Occurrence Handle1:CAS:528:DC%2BD2MXht1aqu7fJ Occurrence Handle10.1016/j.cbpa.2005.10.005

    Article  PubMed  CAS  Google Scholar 

  7. N. Venkatesan J. Yoshimitsu Y. Ito N. Shibata K. Takada (2005) ArticleTitleLiquid filled nanoparticles as a drug delivery tool for protein therapeutics Biomaterials 26 7154–7163 Occurrence Handle15967493 Occurrence Handle1:CAS:528:DC%2BD2MXmvFCqu7o%3D Occurrence Handle10.1016/j.biomaterials.2005.05.012

    Article  PubMed  CAS  Google Scholar 

  8. M. J. Alonso (2004) ArticleTitleNanomedicine for overcoming biological barriers Biomed. Pharmacother. 58 168–172 Occurrence Handle15082339 Occurrence Handle10.1016/j.biopha.2004.01.007 Occurrence Handle1:CAS:528:DC%2BD2cXjtV2gsLs%3D

    Article  PubMed  CAS  Google Scholar 

  9. R. Sykes (2000) ArticleTitleTowards the magic bullet Int. J. Antimicrob. Agents 14 1–12 Occurrence Handle10717495 Occurrence Handle1:CAS:528:DC%2BD3cXhslelu74%3D Occurrence Handle10.1016/S0924-8579(99)00141-7

    Article  PubMed  CAS  Google Scholar 

  10. R. H. Muller C. Jacobs O. Kayser (2001) ArticleTitleNanosuspensions as particulate drug formulations in therapy rational for development and what we can expect for the future Adv. Drug Deliv. Rev. 47 3–19 Occurrence Handle11251242 Occurrence Handle1:CAS:528:DC%2BD3MXhvVajsr0%3D Occurrence Handle10.1016/S0169-409X(00)00118-6

    Article  PubMed  CAS  Google Scholar 

  11. P. L. Felgner T. R. Gadek M. Holm R. Roman H. W. Chan M. Wenz J. P. Northrop G. M. Ringold M. Danielsen (1987) ArticleTitleLipofection: a highly efficient, lipid-mediated DNA-transfection procedure Proc. Natl. Acad. Sci. USA 84 7413–7417 Occurrence Handle2823261 Occurrence Handle1:CAS:528:DyaL1cXjtlSgug%3D%3D Occurrence Handle10.1073/pnas.84.21.7413

    Article  PubMed  CAS  Google Scholar 

  12. J. P. Behr B. Demeneix J. P. Loeffler J. Perez-Mutul (1989) ArticleTitleEfficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA Proc. Natl. Acad. Sci. USA 86 6982–6986 Occurrence Handle2780554 Occurrence Handle1:CAS:528:DyaK3cXhvF2l Occurrence Handle10.1073/pnas.86.18.6982

    Article  PubMed  CAS  Google Scholar 

  13. A. M. Krieg (2001) ArticleTitleImmune effects and mechanisms of action of CpG motifs Vaccines 19 618–622 Occurrence Handle10.1016/S0264-410X(00)00249-8

    Article  Google Scholar 

  14. A. M. Krieg (2003) ArticleTitleCpG motifs: the active ingredient in bacterial extracts? Nat. Med. 9 831–835 Occurrence Handle12835699 Occurrence Handle1:CAS:528:DC%2BD3sXkvFKqtbk%3D Occurrence Handle10.1038/nm0703-831

    Article  PubMed  CAS  Google Scholar 

  15. L. Wang R. K. Prekash C. A. Stein K. K. Koehn D. E. Ruffner (2003) ArticleTitleProgress in the delivery of therapeutic oligonucleotides: organ/cellular distribution and targeted delivery of oligonucleotides in vivo Antisense Nucleic Acid Drug Dev. 13 169–189 Occurrence Handle12954117 Occurrence Handle1:CAS:528:DC%2BD3sXmvVOmsro%3D Occurrence Handle10.1089/108729003768247637

    Article  PubMed  CAS  Google Scholar 

  16. T. Hügle A. Cerny (2003) ArticleTitleCurrent therapy and new molecular approaches to antiviral treatment and prevention of hepatitis Crit. Rev. Med. Virol. 13 361–371 Occurrence Handle10.1002/rmv.397 Occurrence Handle1:CAS:528:DC%2BD3sXpslGgtb4%3D

    Article  CAS  Google Scholar 

  17. Z. Cui (2005) ArticleTitleDNA vaccine Adv. Genet. 54 257–289 Occurrence Handle16096015 Occurrence Handle1:CAS:528:DC%2BD1cXivFWrt7c%3D

    PubMed  CAS  Google Scholar 

  18. R. K. Jain (1987) ArticleTitleTransport of molecules in the tumor interstitium: a review Cancer Res. 47 3039–3051 Occurrence Handle3555767 Occurrence Handle1:CAS:528:DyaL2sXksFKlu7Y%3D

    PubMed  CAS  Google Scholar 

  19. R. K. Jain (2001) ArticleTitleDelivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function J. Control. Release 74 7–25 Occurrence Handle11489479 Occurrence Handle1:CAS:528:DC%2BD3MXlslagu7c%3D Occurrence Handle10.1016/S0168-3659(01)00306-6

    Article  PubMed  CAS  Google Scholar 

  20. M. Links R. Brown (1999) ArticleTitleClinical relevance of the molecular mechanisms of resistance to anti-cancer drugs Expert Rev. Mol. Med. 1999 1–21 Occurrence Handle14585120 Occurrence Handle1:STN:280:DC%2BD3srgvFahuw%3D%3D

    PubMed  CAS  Google Scholar 

  21. R. Krishna L. D. Mayer (2000) ArticleTitleMultidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs Eur. J. Pharm. Sci. 11 265–283 Occurrence Handle11033070 Occurrence Handle1:CAS:528:DC%2BD3cXntF2gtLw%3D Occurrence Handle10.1016/S0928-0987(00)00114-7

    Article  PubMed  CAS  Google Scholar 

  22. I. Brigger C. Dubernet P. Couvreur (2002) ArticleTitleNanoparticles in cancer therapy and diagnosis Adv. Drug Deliv. Rev. 54 631–651 Occurrence Handle12204596 Occurrence Handle1:CAS:528:DC%2BD38XmsVeqtrs%3D Occurrence Handle10.1016/S0169-409X(02)00044-3

    Article  PubMed  CAS  Google Scholar 

  23. J. Kreuter U. Tauber V. Illi (1979) ArticleTitleDistribution and elimination of poly(methyl-2-14C-methacrylate) nanoparticle radioactivity after injection in rats and mice J. Pharm. Sci. 68 1443–1447 Occurrence Handle512896 Occurrence Handle1:CAS:528:DyaL3cXjtlOgsg%3D%3D

    PubMed  CAS  Google Scholar 

  24. J. L. Keyser ParticleDe J. H. Poupaert P. Dumont (1991) ArticleTitlePoly(diethyl methylidenemalonate) nanoparticles as a potential drug carrier: preparation, distribution and elimination after intravenous and peroral administration to mice J. Pharm. Sci. 80 67–70 Occurrence Handle2013853

    PubMed  Google Scholar 

  25. B. A. Conley M. J. Egorin M. Y. Whitacre D. C. Carter E. C. Zuhowski D. A. Echo ParticleVan (1993) ArticleTitlePhase I and pharmacokinetic trial of liposome-encapsulated doxorubicin Cancer Chemother. Pharmacol. 33 107–112 Occurrence Handle8261569 Occurrence Handle1:STN:280:DyaK2c%2FosVymtg%3D%3D Occurrence Handle10.1007/BF00685327

    Article  PubMed  CAS  Google Scholar 

  26. N. Chiannilkulchai N. Ammoury B. Caillou J. P. Devissaguet P. Couvreur (1990) ArticleTitleHepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice Cancer Chemother. Pharmacol. 26 122–126 Occurrence Handle2189589 Occurrence Handle1:CAS:528:DyaK3cXlsFymsbo%3D Occurrence Handle10.1007/BF02897257

    Article  PubMed  CAS  Google Scholar 

  27. A. C. Verdière Particlede C. Dubernet F. Nemati E. Soma M. Appel J. Ferte S. Bernard F. Puisieux P. Couvreur (1997) ArticleTitleReversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action Br. J. Cancer 76 198–205 Occurrence Handle9231919

    PubMed  Google Scholar 

  28. C. E. Soma C. Dubernet G. Barratt F. Nemati M. Appel S. Benita P. Couvreur (1999) ArticleTitleAbility of doxorubicin-loaded nanoparticles to overcome multidrug resistance of tumor cells after their capture by macrophages Pharm. Res. 16 1710–1716 Occurrence Handle10571276 Occurrence Handle1:CAS:528:DyaK1MXnt1Ggs7Y%3D Occurrence Handle10.1023/A:1018902031370

    Article  PubMed  CAS  Google Scholar 

  29. H. B. El-Serag A. C. Mason (1999) ArticleTitleRising incidence of hepatocellular carcinoma in the United States N. Engl. J. Med. 340 745–750 Occurrence Handle10072408 Occurrence Handle1:STN:280:DyaK1M7ls1ensg%3D%3D Occurrence Handle10.1056/NEJM199903113401001

    Article  PubMed  CAS  Google Scholar 

  30. C. L. Lai P. C. Wu G. C. Chan A. S. Lok H. J. Lin (1988) ArticleTitleDoxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial Cancer 62 479–483 Occurrence Handle2839280 Occurrence Handle1:STN:280:DyaL1c3ntVeisg%3D%3D Occurrence Handle10.1002/1097-0142(19880801)62:3<479::AID-CNCR2820620306>3.0.CO;2-L

    Article  PubMed  CAS  Google Scholar 

  31. L. Barraud P. Merle E. Soma L. Lefrançois S. Guerret M. Chevallier C. Dubernet P. Couvreur C. Trepo L. Vitvitski (2005) ArticleTitleIncrease of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo J. Hepatol. 42 736–743 Occurrence Handle15826724 Occurrence Handle1:CAS:528:DC%2BD2MXjtFyktLk%3D Occurrence Handle10.1016/j.jhep.2004.12.035

    Article  PubMed  CAS  Google Scholar 

  32. A. Gabizon S. Amselem D. Gorem R. Cohen S. Druckmann I. Fromer R. Chisin A. Peretz Y. Barenholz (1990) ArticleTitlePreclinical and clinical experience with a doxorubicin liposome preparation J. Liposome Res. 1 491–502

    Google Scholar 

  33. A. Gabizon T. Peretz A. Sulkes S. Amselem R. Ben-Yosef N. Ben-Baruch R. Catane S. Biran Y. Barenholz (1989) ArticleTitleSystemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study Eur. J. Cancer Clin. Oncol. 25 1795–1803 Occurrence Handle2632261 Occurrence Handle1:STN:280:DyaK3c3hsVKltA%3D%3D Occurrence Handle10.1016/0277-5379(89)90350-7

    Article  PubMed  CAS  Google Scholar 

  34. M. C. Woodle D. D. Lasic (1992) ArticleTitleSterically stabilized liposomes Biochim. Biophys. Acta 1113 171–199 Occurrence Handle1510996 Occurrence Handle1:CAS:528:DyaK38XltlOnu78%3D

    PubMed  CAS  Google Scholar 

  35. D. Papahadjopoulos T. M. Allen A. Gabizon E. Mayhew K. Matthay S. K. Huang K. Lee M. C. Woodle D. D. Lasic C. Redemann M. F. Martin (1991) ArticleTitleSterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy Proc. Natl. Acad. Sci. USA 88 11460–11464 Occurrence Handle1763060 Occurrence Handle1:CAS:528:DyaK38XmslWjsg%3D%3D Occurrence Handle10.1073/pnas.88.24.11460

    Article  PubMed  CAS  Google Scholar 

  36. S. I. Jeon J. H. Lee J. D. Andrade P. G. Gennes ParticleDe (1991) ArticleTitleProtein–surface interactions in the presence of polyethylene oxide. I Simplified theory J. Colloid Interface Sci. 142 149–158 Occurrence Handle1:CAS:528:DyaK3MXovVKisg%3D%3D Occurrence Handle10.1016/0021-9797(91)90043-8

    Article  CAS  Google Scholar 

  37. A. Gabizon R. Catane B. Uziely B. Kaufman T. Safra R. Cohen F. Martin A. Huang Y. Barenholz (1994) ArticleTitleProlonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes Cancer Res. 54 987–992 Occurrence Handle8313389 Occurrence Handle1:CAS:528:DyaK2cXhslegs70%3D

    PubMed  CAS  Google Scholar 

  38. L. Illum L. O. Jacobsen R. H. Muller E. Mak S. S. Davis (1987) ArticleTitleSurface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages Biomaterials 8 113–117 Occurrence Handle3580470 Occurrence Handle1:CAS:528:DyaL2sXitF2ntLY%3D Occurrence Handle10.1016/0142-9612(87)90099-8

    Article  PubMed  CAS  Google Scholar 

  39. S. M. Moghimi I. S. Muir L. Illum S. S. Davis V. Kolb-Bachofen (1993) ArticleTitleCoating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum Biochim. Biophys. Acta 1179 157–165 Occurrence Handle8218358 Occurrence Handle1:CAS:528:DyaK2cXjsl2ntw%3D%3D Occurrence Handle10.1016/0167-4889(93)90137-E

    Article  PubMed  CAS  Google Scholar 

  40. R. Gref Y. Minamitake M. T. Peracchia V. Trubetskoy V. Torchilin R. Langer (1994) ArticleTitleBiodegradable long-circulating polymeric nanospheres Science 263 1600–1603 Occurrence Handle8128245 Occurrence Handle1:CAS:528:DyaK2cXit1KktLc%3D

    PubMed  CAS  Google Scholar 

  41. M. T. Peracchia S. Harnisch H. Pinto-Alphandary A. Gulik J. C. Dedieu D. Desmaële J. D’Angelo R. H. Müller P. Couvreur (1999) ArticleTitleVisualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticle Biomaterials 20 1269–1275 Occurrence Handle10403044 Occurrence Handle1:CAS:528:DyaK1MXktVyjtbk%3D Occurrence Handle10.1016/S0142-9612(99)00021-6

    Article  PubMed  CAS  Google Scholar 

  42. G. Storm S. O. Belliot T. Daemen D. D. Lasic (1995) ArticleTitleSurface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system Adv. Drug Deliv. Rev. 17 31–48 Occurrence Handle1:CAS:528:DyaK2MXps1Wltbk%3D Occurrence Handle10.1016/0169-409X(95)00039-A

    Article  CAS  Google Scholar 

  43. S. M. Moghimi A. C. Hunter J. C. Murray (2001) ArticleTitleLong-circulating and target-specific nanoparticles: theory to practice Pharmacol. Rev. 53 283–318 Occurrence Handle11356986 Occurrence Handle1:CAS:528:DC%2BD3MXkt1Gnurc%3D

    PubMed  CAS  Google Scholar 

  44. H. F. Dvorak J. A. Nagy J. T. Dvorak A. M. Dvorak (1988) ArticleTitleIdentification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules Am. J. Pathol. 133 95–109 Occurrence Handle2459969 Occurrence Handle1:STN:280:DyaL1M%2FitlCksQ%3D%3D

    PubMed  CAS  Google Scholar 

  45. Y. Noguchi J. Wu R. Duncan J. Strohalm K. Ulbrich T. Akaike H. Maeda (1998) ArticleTitleEarly phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues Jpn. J. Cancer Res. 89 307–314 Occurrence Handle9600125 Occurrence Handle1:CAS:528:DyaK1cXis1arsbY%3D

    PubMed  CAS  Google Scholar 

  46. H. Maeda J. Wu T. Sawa Y. Matsumura K. Hori (2000) ArticleTitleTumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 271–284 Occurrence Handle10699287 Occurrence Handle1:CAS:528:DC%2BD3cXhtl2qsLo%3D Occurrence Handle10.1016/S0168-3659(99)00248-5

    Article  PubMed  CAS  Google Scholar 

  47. P. Calvo B. Gouritin H. Villarroya F. Eclancher C. Giannavola C. Klein J. P. Andreux P. Couvreur (2002) ArticleTitleQuantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat Eur. J. Neurosci. 15 1317–1326 Occurrence Handle11994126 Occurrence Handle10.1046/j.1460-9568.2002.01967.x

    Article  PubMed  Google Scholar 

  48. P. G. Rose (2005) ArticleTitlePegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer Oncologist 10 205–214 Occurrence Handle15793224 Occurrence Handle1:CAS:528:DC%2BD2MXjsFSnsbg%3D Occurrence Handle10.1634/theoncologist.10-3-205

    Article  PubMed  CAS  Google Scholar 

  49. A. N. Gordon C. O. Granai P. G. Rose J. Hainsworth A. Lopez C. Weissman R. Rosales T. Sharpington (2000) ArticleTitlePhase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer J. Clin. Oncol. 18 3093–3100 Occurrence Handle10963637 Occurrence Handle1:CAS:528:DC%2BD3cXntVCgsb4%3D

    PubMed  CAS  Google Scholar 

  50. A. N. Gordon J. T. Fleagle D. Guthrie D. E. Parkin M. E. Gore A. J. Lacave (2001) ArticleTitleRecurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan J. Clin. Oncol. 19 3312–3322 Occurrence Handle11454878 Occurrence Handle1:CAS:528:DC%2BD3MXlvVamsr8%3D

    PubMed  CAS  Google Scholar 

  51. O. Lyass B. Uziely R. Ben Yosef D. Tzemach N. I. Heshing M. Lotem G. Brufman A. Gabizon (2000) ArticleTitleCorrelation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma Cancer 89 1037–1047 Occurrence Handle10964334 Occurrence Handle1:CAS:528:DC%2BD3cXmsFSqs7o%3D Occurrence Handle10.1002/1097-0142(20000901)89:5<1037::AID-CNCR13>3.0.CO;2-Z

    Article  PubMed  CAS  Google Scholar 

  52. J. M. Ferrero B. Weber D. Lepille H. Orfeuvre M. Combe F. Mayer B. Leduc H. Bourgeois D. Paraiso E. Pujate-Lauraine (2004) ArticleTitleCarboplatin (PA) and pegylated liposomal doxorubicin in patients with advanced ovarian cancer in late (>6 months) relapse (AOCLR): survival results of a GINECO phase II trial Proc. Am. Soc. Clin. Oncol. 23 467s

    Google Scholar 

  53. P. Sapra T. M. Allen (2002) ArticleTitleInternalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs Cancer Res. 62 7190–7194 Occurrence Handle12499256 Occurrence Handle1:CAS:528:DC%2BD3sXhtVyrtQ%3D%3D

    PubMed  CAS  Google Scholar 

  54. P. Sapra T. M. Allen (2003) ArticleTitleLigand-targeted liposomal anticancer drugs Prog. Lipid Res. 42 439–462 Occurrence Handle12814645 Occurrence Handle1:CAS:528:DC%2BD3sXks1altLY%3D Occurrence Handle10.1016/S0163-7827(03)00032-8

    Article  PubMed  CAS  Google Scholar 

  55. V. P. Torchilin (2005) ArticleTitleRecent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 4 145–160 Occurrence Handle15688077 Occurrence Handle1:CAS:528:DC%2BD2MXpt1WlsA%3D%3D Occurrence Handle10.1038/nrd1632

    Article  PubMed  CAS  Google Scholar 

  56. T. L. Andresen S. S. Jensen K. Jorgensen (2005) ArticleTitleAdvanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release Prog. Lipid Res. 44 68–97 Occurrence Handle15748655 Occurrence Handle1:CAS:528:DC%2BD2MXhvVCjtb8%3D Occurrence Handle10.1016/j.plipres.2004.12.001

    Article  PubMed  CAS  Google Scholar 

  57. K. Maruyama O. Ishida T. Takizawa K. Moribe (1999) ArticleTitlePossibility of active targeting to tumor tissues with liposomes Adv. Drug Deliv. Rev. 40 89–102 Occurrence Handle10837782 Occurrence Handle1:CAS:528:DyaK1MXmsFajsLc%3D Occurrence Handle10.1016/S0169-409X(99)00042-3

    Article  PubMed  CAS  Google Scholar 

  58. J. W. Park D. B. Kirpotin K. Hong R. Shalaby Y. Shao U. B. Nielsen J. D. Marks D. Papahadjopoulos C. C. Benz (2001) ArticleTitleTumor targeting using anti-her2 immunoliposomes J. Control. Release 74 95–113 Occurrence Handle11489487 Occurrence Handle1:CAS:528:DC%2BD3MXlslansrk%3D Occurrence Handle10.1016/S0168-3659(01)00315-7

    Article  PubMed  CAS  Google Scholar 

  59. J. A. Kamps G. A. Koning M. J. Velinova H. W. Morselt M. Wilkens A. Gorter J. Donga G. L. Scherphof (2000) ArticleTitleUptake of long-circulating immunoliposomes, directed against colon adenocarcinoma cells, by liver metastases of colon cancer J. Drug Target. 8 235–245 Occurrence Handle11144234 Occurrence Handle1:CAS:528:DC%2BD3cXoslaitbg%3D Occurrence Handle10.3109/10611860008997902

    Article  PubMed  CAS  Google Scholar 

  60. G. A. Koning H. W. M. Morselt A. Gorter T. M. Allen S. Zalipsky G. L. Scherphof J. A. A. M. Kamps (2003) ArticleTitleInteraction of differently designed immunoliposomes with colon cancer cells and Kupffer cells. An in vitro comparison Pharm. Res. 20 1249–1257 Occurrence Handle12948023 Occurrence Handle1:CAS:528:DC%2BD3sXmtVGrtb0%3D Occurrence Handle10.1023/A:1025009300562

    Article  PubMed  CAS  Google Scholar 

  61. R. M. Schiffelers G. A. Koning T. L. M. Hagen ParticleTen M. H. A. M. Fens A. J. Schraa A. P. C. A. Janssen R. J. Kok G. Molema G. Storm (2003) ArticleTitleAnti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin J. Control. Release 91 115–122 Occurrence Handle12932643 Occurrence Handle1:CAS:528:DC%2BD3sXmsVSkurw%3D Occurrence Handle10.1016/S0168-3659(03)00240-2

    Article  PubMed  CAS  Google Scholar 

  62. J. N. Moreira T. Ishida R. Gaspar T. M. Allen (2002) ArticleTitleUse of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity Pharm. Res. 19 265–269 Occurrence Handle11934232 Occurrence Handle1:CAS:528:DC%2BD38XisFGgu74%3D Occurrence Handle10.1023/A:1014434732752

    Article  PubMed  CAS  Google Scholar 

  63. H. Hatakeyama H. Akita K. Maruyama T. Suhara H. Harashima (2004) ArticleTitleFactors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo Int. J. Pharm. 281 25–33 Occurrence Handle15288340 Occurrence Handle1:CAS:528:DC%2BD2cXmtFCmurk%3D Occurrence Handle10.1016/j.ijpharm.2004.05.025

    Article  PubMed  CAS  Google Scholar 

  64. D. A. Eavarone X. Yu R. V. Bellamkonda (2000) ArticleTitleTargeted drug delivery to C6 glioma by transferrin-coupled liposomes J. Biomed. Mater. Res. 51 10–14 Occurrence Handle10813739 Occurrence Handle1:CAS:528:DC%2BD3cXjsFygsbc%3D Occurrence Handle10.1002/(SICI)1097-4636(200007)51:1<10::AID-JBM2>3.0.CO;2-R

    Article  PubMed  CAS  Google Scholar 

  65. O. Ishida K. Maruyama H. Tanahashi M. Iwatsuru K. Sasaki M. Eriguchi H. Yanagie (2001) ArticleTitleLiposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo Pharm. Res. 18 1042–1048 Occurrence Handle11496943 Occurrence Handle1:CAS:528:DC%2BD3MXlsV2itbo%3D Occurrence Handle10.1023/A:1010960900254

    Article  PubMed  CAS  Google Scholar 

  66. R. J. Lee P. S. Low (1994) ArticleTitleDelivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis J. Biol. Chem. 269 3198–3204 Occurrence Handle8106354 Occurrence Handle1:CAS:528:DyaK2cXhsVeqsbk%3D

    PubMed  CAS  Google Scholar 

  67. S. Ni S. M. Stephenson R. J. Lee (2002) ArticleTitleFolate receptor targeted delivery of liposomal daunorubicin into tumor cells Anticancer Res. 22 2131–2135 Occurrence Handle12174894 Occurrence Handle1:CAS:528:DC%2BD38XmsF2ltrY%3D

    PubMed  CAS  Google Scholar 

  68. X. Q. Pan H. Wang R. J. Lee (2003) ArticleTitleAntitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model Pharm. Res. 20 417–422 Occurrence Handle12669962 Occurrence Handle1:CAS:528:DC%2BD3sXhslGrtrw%3D Occurrence Handle10.1023/A:1022656105022

    Article  PubMed  CAS  Google Scholar 

  69. J. J. Sudimack D. Adams J. Rotaru S. Shukla J. Yan M. Sekido R. F. Barth W. Tjarks R. J. Lee (2002) ArticleTitleFolate receptor-mediated liposomal delivery of a lipophilic boron agent to tumor cells in vitro for neutron capture therapy Pharm. Res. 19 1502–1508 Occurrence Handle12425468 Occurrence Handle1:CAS:528:DC%2BD38XnsFSgsbY%3D Occurrence Handle10.1023/A:1020408716807

    Article  PubMed  CAS  Google Scholar 

  70. P. Opanasopit M. Sakai M. Nishikawa S. Kawakami F. Yamashita M. Hashida (2002) ArticleTitleInhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers J. Control. Release 80 283–294 Occurrence Handle11943405 Occurrence Handle1:CAS:528:DC%2BD38XisFyrsbg%3D Occurrence Handle10.1016/S0168-3659(02)00006-8

    Article  PubMed  CAS  Google Scholar 

  71. B. Stella S. Arpicco M. T. Peracchia D. Desmaele J. Hoebeke M. Renoir J. D’Angelo L. Cattel P. Couvreur (2000) ArticleTitleDesign of folic acid-conjugated nanoparticles for drug targeting J. Pharm. Sci. 89 1452–1464 Occurrence Handle11015690 Occurrence Handle1:CAS:528:DC%2BD3cXnvVygtrw%3D Occurrence Handle10.1002/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO;2-P

    Article  PubMed  CAS  Google Scholar 

  72. H. Wartlick K. Michaelis S. Balthasar K. Strebhardt J. Kreuter K. Langer (2004) ArticleTitleHighly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells J. Drug Target. 12 461–471 Occurrence Handle15621671 Occurrence Handle1:CAS:528:DC%2BD2cXhtFSisLfE Occurrence Handle10.1080/10611860400010697

    Article  PubMed  CAS  Google Scholar 

  73. M. B. Yatvin W. Kreutz B. A. Horwitz M. Shinitzky (1980) ArticleTitlepH-sensitive liposomes: possible clinical implications Science 210 1253–1255 Occurrence Handle7434025 Occurrence Handle1:CAS:528:DyaL3MXhsVGhurw%3D

    PubMed  CAS  Google Scholar 

  74. J. Shin P. Shum D. H. Thompson (2003) ArticleTitleAcid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids J. Control. Release 91 187–200 Occurrence Handle12932651 Occurrence Handle1:CAS:528:DC%2BD3sXmsVSrsrw%3D Occurrence Handle10.1016/S0168-3659(03)00232-3

    Article  PubMed  CAS  Google Scholar 

  75. G. Helmlinger F. Yuan M. Dellian R. K. Jain (1997) ArticleTitleInterstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation Nat. Med. 3 177–182 Occurrence Handle9018236 Occurrence Handle1:CAS:528:DyaK2sXpsVOktw%3D%3D Occurrence Handle10.1038/nm0297-177

    Article  PubMed  CAS  Google Scholar 

  76. G. Helmlinger A. Sckell M. Dellian N. S. Forbes R. K. Jain (2002) ArticleTitleAcid production in glycolysis-impaired tumors provides new insights into tumor metabolism Clin. Cancer Res. 8 1284–1291 Occurrence Handle11948144 Occurrence Handle1:CAS:528:DC%2BD38XjsF2ltb4%3D

    PubMed  CAS  Google Scholar 

  77. E. Fattal P. Couvreur C. Dubernet (2004) ArticleTitle“Smart” delivery of antisense oligonucleotides by anionic pH-sensitive liposomes Adv. Drug Deliv. Rev. 56 931–946 Occurrence Handle15066753 Occurrence Handle1:CAS:528:DC%2BD2cXivVGitLs%3D Occurrence Handle10.1016/j.addr.2003.10.037

    Article  PubMed  CAS  Google Scholar 

  78. S. Simoes J. N. Moreira C. Fonseca N. Düzgünes M. C. Pedroso de Lima (2004) ArticleTitleOn the formulation of pH-sensitive liposomes with long circulation times Adv. Drug Deliv. Rev. 56 947–965 Occurrence Handle15066754 Occurrence Handle1:CAS:528:DC%2BD2cXivVGitLg%3D Occurrence Handle10.1016/j.addr.2003.10.038

    Article  PubMed  CAS  Google Scholar 

  79. A. Mori A. L. Klibanov V. P. Torchilin L. Huang (1991) ArticleTitleInfluence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo FEBS Lett. 284 263–266 Occurrence Handle2060647 Occurrence Handle1:CAS:528:DyaK3MXkslyrsr4%3D Occurrence Handle10.1016/0014-5793(91)80699-4

    Article  PubMed  CAS  Google Scholar 

  80. K. Kono K. Zenitani T. Takagishi (1994) ArticleTitleNovel pH-sensitive liposomes: liposomes bearing a poly(ethylene glycol) derivative with carboxyl groups Biochim. Biophys. Acta 1193 1–9 Occurrence Handle8038177 Occurrence Handle1:CAS:528:DyaK2cXls1ertrY%3D Occurrence Handle10.1016/0005-2736(94)90325-5

    Article  PubMed  CAS  Google Scholar 

  81. E. Roux M. Francis F. M. Winnik J. C. Leroux (2002) ArticleTitlePolymer based pH-sensitive carriers as a means to improve the cytoplasmic delivery of drugs Int. J. Pharm. 242 25–36 Occurrence Handle12176222 Occurrence Handle1:CAS:528:DC%2BD38Xmt1ygur8%3D Occurrence Handle10.1016/S0378-5173(02)00183-7

    Article  PubMed  CAS  Google Scholar 

  82. D. Collins D. C. Litzinger L. Huang (1990) ArticleTitleStructural and functional comparisons of pH-sensitive liposomes composed of phosphatidylethanolamine and three different diacylsuccinylglycerols Biochim. Biophys. Acta 1025 234–242 Occurrence Handle2364079 Occurrence Handle1:CAS:528:DyaK3cXlvFOktLY%3D Occurrence Handle10.1016/0005-2736(90)90102-T

    Article  PubMed  CAS  Google Scholar 

  83. K. Kono T. Igawa T. Takagishi (1997) ArticleTitleCytoplasmic delivery of calcein mediated by liposomes modified with a pH-sensitive poly(ethylene glycol) derivative Biochim. Biophys. Acta 1325 143–154 Occurrence Handle9168140 Occurrence Handle1:CAS:528:DyaK2sXjt1WrsrY%3D Occurrence Handle10.1016/S0005-2736(96)00244-1

    Article  PubMed  CAS  Google Scholar 

  84. V. A. Slepushkin S. Simoens P. Dazin M. S. Newman L. S. Guo M. C. Pedroso de Lima N. Duzgunes (1997) ArticleTitleSterically stabilized pH-sensitive liposomes. Intracellular delivery of aqueous contents and prolonged circulation in vivo J. Biol. Chem. 272 2382–2388 Occurrence Handle8999949 Occurrence Handle1:CAS:528:DyaK2sXotFarsg%3D%3D Occurrence Handle10.1074/jbc.272.4.2382

    Article  PubMed  CAS  Google Scholar 

  85. D. Liu L. Huang (1990) ArticleTitlepH-Sensitive, plasma-stable liposomes with relatively prolonged residence in circulation Biochim. Biophys. Acta 1022 348–354 Occurrence Handle2317486 Occurrence Handle1:CAS:528:DyaK3cXhvVGks7Y%3D Occurrence Handle10.1016/0005-2736(90)90284-U

    Article  PubMed  CAS  Google Scholar 

  86. M. B. Yatvin J. N. Weinstein W. H. Dennis R. Blumenthal (1978) ArticleTitleDesign of liposomes for enhanced local release of drugs by hyperthermia Science 202 1290–1293 Occurrence Handle364652 Occurrence Handle1:CAS:528:DyaE1MXpt1elsQ%3D%3D

    PubMed  CAS  Google Scholar 

  87. G. Kong G. Anyarambhatla W. P. Petros R. D. Braun O. M. Colvin D. Needham M. W. Dewhirst (2000) ArticleTitleEfficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release Cancer Res. 60 6950–6957 Occurrence Handle11156395 Occurrence Handle1:CAS:528:DC%2BD3MXjsVOjtA%3D%3D

    PubMed  CAS  Google Scholar 

  88. D. Needham G. Anyarambhatla G. Kong M. W. Dewhirs (2000) ArticleTitleA new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model Cancer Res. 60 1197–1201 Occurrence Handle10728674 Occurrence Handle1:CAS:528:DC%2BD3cXhvFWrsb0%3D

    PubMed  CAS  Google Scholar 

  89. T. L. Andresen J. Davidsen M. Begtrup O. G. Mouritsen K. Jorgensen (2004) ArticleTitleEnzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs J. Med. Chem. 47 1694–1703 Occurrence Handle15027860 Occurrence Handle1:CAS:528:DC%2BD2cXhsVOit70%3D Occurrence Handle10.1021/jm031029r

    Article  PubMed  CAS  Google Scholar 

  90. T. L. Andresen O. G. Mouritsen M. Begtrup K. Jorgensen (2002) ArticleTitlePhospholipase A2 activity: dependence on liposome surface charge and polymer coverage Biophys. J. 82 148c

    Google Scholar 

  91. C. C. Pak R. K. Erukulla P. L. Ahl A. S. Janoff P. Meers (1999) ArticleTitleElastase activated liposomal delivery to nucleated cells Biochim. Biophys. Acta 1419 111–126 Occurrence Handle10407064 Occurrence Handle1:CAS:528:DyaK1MXltV2mtLk%3D Occurrence Handle10.1016/S0005-2736(98)00256-9

    Article  PubMed  CAS  Google Scholar 

  92. S. C. Davis F. C. Szoka SuffixJr. (1998) ArticleTitleCholesterol phosphate derivatives: synthesis and incorporation into a phosphatase and calcium-sensitive triggered release liposome Bioconjug. Chem. 9 783–792 Occurrence Handle9815173 Occurrence Handle1:CAS:528:DyaK1cXmsVWjs7w%3D Occurrence Handle10.1021/bc980047y

    Article  PubMed  CAS  Google Scholar 

  93. A. Mueller B. Bondurant D. F. O’Brien (2000) ArticleTitleVisible-light stimulated destabilization of PEG-liposomes Macromolecules 33 4799–4804 Occurrence Handle1:CAS:528:DC%2BD3cXjs1KksL4%3D Occurrence Handle10.1021/ma000055l

    Article  CAS  Google Scholar 

  94. B. Bonnemain (1998) ArticleTitleSuperparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review J. Drug Target. 6 167–174 Occurrence Handle9888302 Occurrence Handle1:CAS:528:DyaK1MXkvFKguw%3D%3D Occurrence Handle10.3109/10611869808997890

    Article  PubMed  CAS  Google Scholar 

  95. D. Pouliquen J. J. Jeune ParticleLe R. Perdrisot A. Ermias P. Jallet (1991) ArticleTitleIron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism Magn. Reson. Imaging 9 275–283 Occurrence Handle1881245 Occurrence Handle1:CAS:528:DyaK3MXlslyhtbw%3D Occurrence Handle10.1016/0730-725X(91)90412-F

    Article  PubMed  CAS  Google Scholar 

  96. E. Okon D. Pouliquen P. Okon Z. V. Kovaleva T. P. Stepanova S. G. Lavit B. N. Kudryavtsev P. Jallet (1994) ArticleTitleBiodegradation of magnetite dextran nanoparticles in the rat. A histologic and biophysical study Lab. Invest. 71 895–903 Occurrence Handle7807971 Occurrence Handle1:CAS:528:DyaK2MXjs12gsbg%3D

    PubMed  CAS  Google Scholar 

  97. A. Chachuat B. Bonnemain (1995) ArticleTitleEuropean clinical experience with Endorem. A new contrast agent for liver MRI in 1000 patients Radiology 35 S274–S276 Occurrence Handle1:STN:280:DyaK287gvVansw%3D%3D

    CAS  Google Scholar 

  98. S. Kubaska D. V. Sahani S. Saini P. F. Hahn E. Halpern (2001) ArticleTitleDual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterisation Clin. Radiol. 56 410–415 Occurrence Handle11384141 Occurrence Handle1:STN:280:DC%2BD3MzhtFKlsA%3D%3D Occurrence Handle10.1053/crad.2000.0673

    Article  PubMed  CAS  Google Scholar 

  99. R. Weissleder G. Elizondo D. D. Stark P. F. Hahn J. Marfil J. F. Gonzalez S. Saini L. E. Todd J. T. Ferrucci (1989) ArticleTitleThe diagnosis of splenic lymphoma by MR imaging: value of superparamagnetic iron oxide A.J.R. Am. J. Roentgenol. 152 175–180 Occurrence Handle1:STN:280:DyaL1M%2FnsVCqsg%3D%3D

    CAS  Google Scholar 

  100. A. Iannone R. L. Magin T. Walczak M. Federico H. M. Swartz A. Tomasi V. Vannini (1991) ArticleTitleBlood clearance of dextran magnetite particles determined by a noninvasive in vivo ESR method Magn. Reson. Med. 22 435–442 Occurrence Handle1725919 Occurrence Handle1:STN:280:DyaK383lt1Kqsg%3D%3D

    PubMed  CAS  Google Scholar 

  101. R. Weissleder A. Bogdanov E. A. Neuwelt M. Papisov (1995) ArticleTitleLong-circulating iron oxides for MR imaging Adv. Drug Deliv. Rev. 16 321–334 Occurrence Handle1:CAS:528:DyaK2MXpt1amt7s%3D Occurrence Handle10.1016/0169-409X(95)00033-4

    Article  CAS  Google Scholar 

  102. K. Turetschek S. Huber E. Floyd T. Helbich T. P. Roberts D. M. Shames K. S. Tarlo M. F. Wendland R. C. Brasch (2001) ArticleTitleMR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation Radiology 218 562–569 Occurrence Handle11161179 Occurrence Handle1:STN:280:DC%2BD3M3lvVehsw%3D%3D

    PubMed  CAS  Google Scholar 

  103. Y. Anzai S. McLachlan M. Morris R. Saxton R. B. Lufkin (1994) ArticleTitleDextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck Am. J. Neuroradiol. 15 87–94 Occurrence Handle7511324 Occurrence Handle1:STN:280:DyaK2c7ovFCkug%3D%3D

    PubMed  CAS  Google Scholar 

  104. K. Lind M. Kresse N. P. Debus R. H. Muller (2002) ArticleTitleA novel formulation for superparamagnetic iron oxide (SPIO) particles enhancing MR lymphograpy: comparison of physicochemical properties and the in vivo behaviour J. Drug Target. 10 221–230 Occurrence Handle12075823 Occurrence Handle1:CAS:528:DC%2BD38XjslSlt7s%3D Occurrence Handle10.1080/10611860290022651

    Article  PubMed  CAS  Google Scholar 

  105. A. Moore R. Weissleder A. Bogdanov SuffixJr. (1997) ArticleTitleUptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages J. Magn. Reson. Imaging 7 1140–1145 Occurrence Handle9400860 Occurrence Handle1:STN:280:DyaK1c%2Fmt1SgsA%3D%3D

    PubMed  CAS  Google Scholar 

  106. A. Moore J. P. Basilion E. A. Chiocca R. Weissleder (1998) ArticleTitleMeasuring transferrin receptor gene expression by NMR imaging Biochim. Biophys. Acta 1402 239–249 Occurrence Handle9606982 Occurrence Handle1:CAS:528:DyaK1cXivVOqtLY%3D Occurrence Handle10.1016/S0167-4889(98)00002-0

    Article  PubMed  CAS  Google Scholar 

  107. P. Varallyay G. Nesbit L. L. Muldoon R. R. Nixon J. Delashaw J. I. Cohen A. Petrillo D. Rink E. A. Neuwelt (2002) ArticleTitleComparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors Am. J. Neuroradiol. 23 510–519 Occurrence Handle11950637

    PubMed  Google Scholar 

  108. L. G. Remsen C. I. McCormick S. Roman-Goldstein G. Nilaver R. Weissleder A. Bogdanov I. Hellstrom R. A. Kroll E. A. Neuwelt (1996) ArticleTitleMR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis Am. J. Neuroradiol. 17 411–418 Occurrence Handle8881233 Occurrence Handle1:STN:280:DyaK2s%2FjsFGrtw%3D%3D

    PubMed  CAS  Google Scholar 

  109. D. Artemov N. Mori B. Okollie Z. M. Bhujwalla (2003) ArticleTitleMR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles Magn. Reson. Med. 49 403–408 Occurrence Handle12594741 Occurrence Handle1:CAS:528:DC%2BD3sXisVGktL4%3D Occurrence Handle10.1002/mrm.10406

    Article  PubMed  CAS  Google Scholar 

  110. M. Shinkai M. Yanase M. Suzuki H. Honda T. Wakabayashi J. Yoshida T. Kobayashi (1999) ArticleTitleIntracellular hyperthermia for cancer using magnetite cationic liposomes J. Magn. Magn. Mater. 194 176–184 Occurrence Handle1:CAS:528:DyaK1MXitVKltrs%3D Occurrence Handle10.1016/S0304-8853(98)00586-1

    Article  CAS  Google Scholar 

  111. M. Yanase M. Shinkai H. Honda T. Wakabayashi J. Yoshida T. Kobayashi (1998) ArticleTitleAntitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes Jpn. J. Cancer Res. 89 775–782 Occurrence Handle9738985 Occurrence Handle1:CAS:528:DyaK1cXltlCju78%3D

    PubMed  CAS  Google Scholar 

  112. I. Hilger W. Andrä R. Hergt R. Hiergeist H. Schubert W. A. Kaiser (2001) ArticleTitleElectromagnetic heating of breast tumors in interventional radiology: in vitro and in vivo studies in human cadavers and mice Radiology 218 570–575 Occurrence Handle11161180 Occurrence Handle1:STN:280:DC%2BD3M3lvVehsA%3D%3D

    PubMed  CAS  Google Scholar 

  113. A. Jordan P. Wust R. Scholz H. Faehling J. Krause R. Felix (1997) Magnetic fluid hyperthermia (MFH) U. Hafeli W. Schutt J. Teller U. Hdfeli W. Schutt M. Zborowski (Eds) Scientific and Clinical Applications of Magnetic Carriers Plenum Press New York 569–595

    Google Scholar 

  114. A. Jordan R. Scholz K. Maier-Hauff M. Johannsen P. Wust J. Nadobny H. Schirra H. Schmidt S. Deger S. Loening W. Lanksch R. Felix (2001) ArticleTitlePresentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia J. Magn. Magn. Mater. 225 118–126 Occurrence Handle1:CAS:528:DC%2BD3MXislaiurc%3D Occurrence Handle10.1016/S0304-8853(00)01239-7

    Article  CAS  Google Scholar 

  115. A. Halbreich J. Roger J. N. Pons D. Geldwerth M. F. Silva ParticleDa M. Roudier J. C. Bacri (1998) ArticleTitleBiomedical applications of maghemite ferrofluid Biochimie 80 379–390 Occurrence Handle9782379 Occurrence Handle1:CAS:528:DyaK1cXmt1Sntbw%3D Occurrence Handle10.1016/S0300-9084(00)80006-1

    Article  PubMed  CAS  Google Scholar 

  116. J. C. Bacri M. F. Silva ParticleDa R. Perzynski J. N. Pons J. Roger D. Sabolovic A. Halbreich (1997) Use of magnetic nanoparticles for thermolysis of cells in a ferrofluid U. Hafeli W. Schutt J. Teller U. Hdfeli W. Schutt M. Zborowski (Eds) Scientific and Clinical Applications of Magnetic Carriers Plenum Press New York 597–606

    Google Scholar 

  117. A. Jordan R. Scholz P. Wust H. Schirra (1999) ArticleTitleEndocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro J. Magn. Magn. Mater. 194 185–196 Occurrence Handle1:CAS:528:DyaK1MXitVKltrg%3D Occurrence Handle10.1016/S0304-8853(98)00558-7

    Article  CAS  Google Scholar 

  118. M. Shinkai B. Le H. Honda K. Yoshikawa K. Shimizu S. Saga T. Wakabayashi J. Yoshida T. Kobayashi (2001) ArticleTitleTargeting hyperthermia for renal cell carcinoma using human MN antigen-specific magnetoliposomes Jpn. J. Cancer Res. 92 1138–1145 Occurrence Handle11676866 Occurrence Handle1:CAS:528:DC%2BD3MXptVGgu7g%3D

    PubMed  CAS  Google Scholar 

  119. F. Sonvico S. Mornet S. Vasseur C. Dubernet D. Jaillard J. Degrouard J. Hoebeke E. Duguet P. Colombo P. Couvreur (2005) ArticleTitleFolate-conjugated iron oxide nanoparticles for solid tumor targeting as potential “Specific Magnetic Hyperthermia Mediators: Synthesis, Physicochemical Characterization, and in Vitro Experiments” Bioconjug. Chem. 16 1181–1188 Occurrence Handle16173796 Occurrence Handle1:CAS:528:DC%2BD2MXpsleqsrs%3D Occurrence Handle10.1021/bc050050z

    Article  PubMed  CAS  Google Scholar 

  120. C. M. Pitsillides E. K. Joe X. Wie R. R. Anderson C. P. Lin (2003) ArticleTitleSelective cell targeting with light-adsorbing microparticles and nanoparticles Biophys. J. 84 4023–4032 Occurrence Handle12770906 Occurrence Handle1:CAS:528:DC%2BD3sXksVKnsbg%3D Occurrence Handle10.1016/S0006-3495(03)75128-5

    Article  PubMed  CAS  Google Scholar 

  121. C. P. Lin M. W. Kelly S. A. Sibayan M. A. Latina R. R. Anderson (1999) ArticleTitleSelective cell killing by microparticle absorption of pulsed laser radiation IEEE J. Sel. Top. Quantum Electron. 5 963–968 Occurrence Handle1:CAS:528:DyaK1MXntVWrurw%3D Occurrence Handle10.1109/2944.796318

    Article  CAS  Google Scholar 

  122. F. Shi A. L. Rakhmilevich C. P. Heise K. Oshikawa P. M. Sondel N. S. Yang D. M. Mahvi (2002) ArticleTitleIntratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model Mol. Cancer Ther. 1 949–957 Occurrence Handle12481417 Occurrence Handle1:CAS:528:DC%2BD3sXmvFOntA%3D%3D

    PubMed  CAS  Google Scholar 

  123. K. Kawabata T. Takakura M. Hashida (1995) ArticleTitleThe fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake Pharm. Res. 12 825–830 Occurrence Handle7667185 Occurrence Handle1:CAS:528:DyaK2MXmtV2qurc%3D Occurrence Handle10.1023/A:1016248701505

    Article  PubMed  CAS  Google Scholar 

  124. K. Ewert A. Ahmad H. M. Evans H. W. Schmidt C. R. Safinya (2002) ArticleTitleEfficient synthesis and cell-transfection properties of a new multivalent cationic lipid for nonviral gene delivery J. Med. Chem. 45 5023–5029 Occurrence Handle12408712 Occurrence Handle1:CAS:528:DC%2BD38XnvV2lurw%3D Occurrence Handle10.1021/jm020233w

    Article  PubMed  CAS  Google Scholar 

  125. H. Gao K. M. Hui (2001) ArticleTitleSynthesis of a novel series of cationic lipids that can act as efficient gene delivery vehicles through systematic heterocyclic substitution of cholesterol derivatives Gene Ther. 8 855–863 Occurrence Handle11423933 Occurrence Handle1:CAS:528:DC%2BD3MXktFOrtr0%3D Occurrence Handle10.1038/sj.gt.3301471

    Article  PubMed  CAS  Google Scholar 

  126. X. Gao L. Huang (1996) ArticleTitlePotentiation of cationic liposome-mediated gene delivery by polycations Biochemistry 35 1027–1036 Occurrence Handle8547238 Occurrence Handle1:CAS:528:DyaK28XhsFKjsA%3D%3D Occurrence Handle10.1021/bi952436a

    Article  PubMed  CAS  Google Scholar 

  127. N. T. Ueno C. Bartholomeusz W. Xia P. Anklesaria E. M. Bruckheimer E. Mebel R. Paul S. Li G. H. Yo L. Huang M. C. Hung (2002) ArticleTitleSystemic gene therapy in human xenograft tumor models by liposomal delivery of the E1A gene Cancer Res. 62 6712–6716 Occurrence Handle12438271 Occurrence Handle1:CAS:528:DC%2BD38XovFOksLc%3D

    PubMed  CAS  Google Scholar 

  128. A. Y. Nikitin M. I. Juarez-Perez S. Li L. Huang W. H. Lee (1999) ArticleTitleRB-mediated suppression of spontaneous multiple neuroendocrine neoplasia and lung metastases in Rb+/− mice Proc. Natl. Acad. Sci. USA 96 3916–3921 Occurrence Handle10097138 Occurrence Handle1:CAS:528:DyaK1MXjslChsLk%3D Occurrence Handle10.1073/pnas.96.7.3916

    Article  PubMed  CAS  Google Scholar 

  129. T. B. Wyman F. Nicol O. Zelphati P. V. Scaria C. Plank F. C. Szoka SuffixJr. (1997) ArticleTitleDesign, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers Biochemistry 36 3008–3017 Occurrence Handle9062132 Occurrence Handle1:CAS:528:DyaK2sXhslGjsr4%3D Occurrence Handle10.1021/bi9618474

    Article  PubMed  CAS  Google Scholar 

  130. G. Y. Wu C. H. Wu (1987) ArticleTitleReceptor-mediated in vitro gene transformation by a soluble DNA carrier system J. Biol. Chem. 262 4429–4432 Occurrence Handle3558345 Occurrence Handle1:CAS:528:DyaL2sXhslShsL0%3D

    PubMed  CAS  Google Scholar 

  131. C. M. Ward M. L. Read L. W. Seymour (2001) ArticleTitleSystemic circulation of poly(l-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy Blood 97 2221–2229 Occurrence Handle11290582 Occurrence Handle1:CAS:528:DC%2BD3MXivFOgt78%3D Occurrence Handle10.1182/blood.V97.8.2221

    Article  PubMed  CAS  Google Scholar 

  132. O. Boussif F. Lezoualc’h M. A. Zanta M. D. Mergny D. Scherman B. Demeneix J. P. Behr (1995) ArticleTitleA versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine Proc. Natl. Acad. Sci. USA 92 7297–7301 Occurrence Handle7638184 Occurrence Handle1:CAS:528:DyaK2MXntlKmt7s%3D Occurrence Handle10.1073/pnas.92.16.7297

    Article  PubMed  CAS  Google Scholar 

  133. A. Kichler C. Leborgne E. Coeytaux O. Danos (2001) ArticleTitlePolyethylenimine-mediated gene delivery: a mechanistic study J. Gene Med. 3 135–144 Occurrence Handle11318112 Occurrence Handle1:STN:280:DC%2BD3MvkslGksQ%3D%3D Occurrence Handle10.1002/jgm.173

    Article  PubMed  CAS  Google Scholar 

  134. H. Lee J. H. Jeong T. G. Park (2002) ArticleTitlePEG grafted polylysine with fusogenic peptide for gene delivery: high transfection efficiency with low cytotoxicity J. Control. Release 79 283–291 Occurrence Handle11853938 Occurrence Handle1:CAS:528:DC%2BD38XhtlSlsbo%3D Occurrence Handle10.1016/S0168-3659(02)00002-0

    Article  PubMed  CAS  Google Scholar 

  135. E. Wagner M. Zenke M. Cotten H. Beug M. L. Birnstiel (1990) ArticleTitleTransferrin-polycation conjugates as carriers for DNA uptake into cells Proc. Natl. Acad. Sci. USA 87 3410–3414 Occurrence Handle2333290 Occurrence Handle1:CAS:528:DyaK3MXitVWjtrc%3D Occurrence Handle10.1073/pnas.87.9.3410

    Article  PubMed  CAS  Google Scholar 

  136. W. Suh J. K. Chung S. H. Park S. W. Kim (2001) ArticleTitleAnti-JL1 antibody-conjugated poly(l-lysine) for targeted gene delivery to leukemia T cells J. Control. Release 72 171–178 Occurrence Handle11389996 Occurrence Handle1:CAS:528:DC%2BD3MXktVGks70%3D Occurrence Handle10.1016/S0168-3659(01)00273-5

    Article  PubMed  CAS  Google Scholar 

  137. C. M. Ward M. Pechar D. Oupicky K. Ulbrich L. W. Seymour (2002) ArticleTitleModification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate-mediated targeting in vitro and prolonged plasma circulation in vivo J. Gene Med. 4 536–547 Occurrence Handle12221647 Occurrence Handle1:CAS:528:DC%2BD38XosVWru74%3D Occurrence Handle10.1002/jgm.296

    Article  PubMed  CAS  Google Scholar 

  138. R. Kircheis S. Schuller S. Brunner M. Ogris K. H. Heider W. Zauner E. Wagner (1999) ArticleTitlePolycation-based DNA complexes for tumor-targeted gene delivery in vivo J. Gene Med. 1 111–120 Occurrence Handle10738575 Occurrence Handle1:CAS:528:DyaK1MXjvVCmtLk%3D Occurrence Handle10.1002/(SICI)1521-2254(199903/04)1:2<111::AID-JGM22>3.0.CO;2-Y

    Article  PubMed  CAS  Google Scholar 

  139. G. Stingl E. B. Brocker R. Mertelsmann K. Wolff S. Schreiber E. Kampgen A. Schneeberger W. Dummer U. Brennscheid H. Veelken M. L. Birnstiel K. Zatloukal W. Schmidt G. Maass E. Wagner M. Baschle M. Giese E. R. Kempe H. A. Weber T. Voigt (1996) ArticleTitlePhase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene Hum. Gene Ther. 7 551–563 Occurrence Handle8800750 Occurrence Handle1:CAS:528:DyaK28Xit12ht74%3D

    PubMed  CAS  Google Scholar 

  140. J. Chen S. Gamou A. Takayanagi N. Shimizu (1994) ArticleTitleA novel gene delivery system using EGF receptor-mediated endocytosis FEBS Lett. 338 167–169 Occurrence Handle8307175 Occurrence Handle1:CAS:528:DyaK2cXhsFGitbY%3D Occurrence Handle10.1016/0014-5793(94)80357-9

    Article  PubMed  CAS  Google Scholar 

  141. A. Boletta A. Benigni J. Lutz G. Remuzzi M. R. Soria L. Monaco (1997) ArticleTitleNonviral gene delivery to the rat kidney with polyethylenimine Hum. Gene Ther. 8 1243–1251 Occurrence Handle9215741 Occurrence Handle1:CAS:528:DyaK2sXksF2nt70%3D

    PubMed  CAS  Google Scholar 

  142. M. Köping-Höggard Y. S. Mel’nikova K. M. Varum B. Lindman P. Artursson (2003) ArticleTitleRelationship between the physical shape and the efficiency of oligomeric chitosan as a gene delivery system in vitro and in vivo J. Gene Med. 5 130–141 Occurrence Handle12539151 Occurrence Handle10.1002/jgm.327 Occurrence Handle1:CAS:528:DC%2BD3sXit1Glsr8%3D

    Article  PubMed  CAS  Google Scholar 

  143. L. Vincent J. Varet J. Y. Pille H. Bompais P. Opolon A. Maksimenko C. Malvy M. Mirshahi H. Lu J. P. Vannier C. Soria H. Li (2003) ArticleTitleEfficacy of dendrimer-mediated angiostatin and TIMP-2 gene delivery on inhibition of tumor growth and angiogenesis: in vitro and in vivo studies Int. J. Cancer. 105 419–429 Occurrence Handle12704680 Occurrence Handle1:CAS:528:DC%2BD3sXktlWit74%3D Occurrence Handle10.1002/ijc.11105

    Article  PubMed  CAS  Google Scholar 

  144. P. Wetering ParticleVan de J. Y. Cherng H. Talsma W. E. Hennink (1997) ArticleTitleRelation between transfection efficiency and cytotoxicity of poly(2-(dimethylamino)ethyl methacrylate)/plasmid complexes J. Control. Release 49 59–69 Occurrence Handle10.1016/S0168-3659(97)00059-X

    Article  Google Scholar 

  145. A. El-Aneed (2004) ArticleTitleAn overview of current delivery systems in cancer gene therapy J. Control. Release 94 1–14 Occurrence Handle14684267 Occurrence Handle1:CAS:528:DC%2BD3sXpslCmu70%3D Occurrence Handle10.1016/j.jconrel.2003.09.013

    Article  PubMed  CAS  Google Scholar 

  146. C. Chavany T. Saison-Behmoaras T. Doan ParticleLe F. Puisieux P. Couvreur C. Hélène (1994) ArticleTitleAdsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increase their cellular uptake Pharm. Res. 11 1370–1378 Occurrence Handle7816773 Occurrence Handle1:CAS:528:DyaK2cXmtFarsrs%3D Occurrence Handle10.1023/A:1018923301967

    Article  PubMed  CAS  Google Scholar 

  147. G. Schwab C. Chavany I. Duroux G. Goubin J. Lebeau C. Hélène T. Saison-Behmoaras (1994) ArticleTitleAntisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice Proc. Natl. Acad. Sci. USA 91 10460–10464 Occurrence Handle7937975 Occurrence Handle1:CAS:528:DyaK2MXhslelsr0%3D Occurrence Handle10.1073/pnas.91.22.10460

    Article  PubMed  CAS  Google Scholar 

  148. L. Tondelli A. Ricca M. Laus M. Lelli G. Citro (1998) ArticleTitleHighly efficient cellular uptake of c-myb antisense oligonucleotides through specifically designed polymeric nanospheres Nucleic Acids Res. 26 5425–5431 Occurrence Handle9826768 Occurrence Handle1:CAS:528:DyaK1MXis1Knsw%3D%3D Occurrence Handle10.1093/nar/26.23.5425

    Article  PubMed  CAS  Google Scholar 

  149. A. R. Thierry A. Rahman A. Dritschilo (1993) ArticleTitleOvercoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides Biochem. Biophys. Res. Commun. 190 952–960 Occurrence Handle8094959 Occurrence Handle1:CAS:528:DyaK3sXktFGhsb0%3D Occurrence Handle10.1006/bbrc.1993.1142

    Article  PubMed  CAS  Google Scholar 

  150. S. Vinogradov E. Batrakova A. Kabanov (1999) ArticleTitlePoly(ethylene glycol)–polyethyleneimine NanoGel TM particles: novel drug delivery systems for antisense oligonucleotides Colloids Surf., B Biointerfaces 16 291–304 Occurrence Handle1:CAS:528:DyaK1MXnvFylu7Y%3D Occurrence Handle10.1016/S0927-7765(99)00080-6

    Article  CAS  Google Scholar 

  151. W. A. May M. L. Gishizky S. L. Lessnick L. B. Lunsford B. C. Lewis O. Delattre J. Zucman G. Thomas C. T. Dennt (1993) ArticleTitleEwing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation Proc. Natl. Acad. Sci. USA 90 5752–5756 Occurrence Handle8516324 Occurrence Handle1:CAS:528:DyaK3sXltFCmsbw%3D Occurrence Handle10.1073/pnas.90.12.5752

    Article  PubMed  CAS  Google Scholar 

  152. K. Tanaka T. Iwakuma K. Harimaya H. Sato Y. Iwamoto (1997) ArticleTitleEWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells J. Clin. Invest. 99 239–247 Occurrence Handle9005992 Occurrence Handle1:CAS:528:DyaK2sXntVOjug%3D%3D Occurrence Handle10.1172/JCI119152

    Article  PubMed  CAS  Google Scholar 

  153. G. Lambert J. R. Bertrand E. Fattal F. Subra H. Pinto-Alphandary C. Malvy C. Auclair P. Couvreur (2000) ArticleTitleEWS Fli-1 antisense nanocapsules inhibits Ewing sarcoma-related tumor in mice Biochem. Biophys. Res. Commun. 279 401–406 Occurrence Handle11118299 Occurrence Handle1:CAS:528:DC%2BD3cXovVCntL8%3D Occurrence Handle10.1006/bbrc.2000.3963

    Article  PubMed  CAS  Google Scholar 

  154. A. Maksimenko C. Malvy G. Lambert J. R. Bertrand E. Fattal J. Maccario P. Couvreur (2003) ArticleTitleOligonucleotides targeted against a junction oncogene are made efficient by nanotechnologies Pharm. Res. 20 1565–1567 Occurrence Handle14620508 Occurrence Handle1:CAS:528:DC%2BD3sXotFClsr0%3D Occurrence Handle10.1023/A:1026122914852

    Article  PubMed  CAS  Google Scholar 

  155. N. Toub C. Angiari D. Eboué E. Fattal J. P. Tenu T. Doan ParticleLe P. Couvreur (2005) ArticleTitleCellular fate of oligonucleotides when delivered by nanocapsules of poly(isobutylcyanoacrylate) J. Control. Release 106 209–213 Occurrence Handle15951045 Occurrence Handle1:CAS:528:DC%2BD2MXntlShsr8%3D Occurrence Handle10.1016/j.jconrel.2005.03.029

    Article  PubMed  CAS  Google Scholar 

  156. Z. Hassani G. F. Lemkine P. Erbacher K. Palmier G. Alfama C. Giovannangeli J. P. Behr B. A. Demeneix (2005) ArticleTitleLipid-mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels J. Gene Med. 7 198–207 Occurrence Handle15515135 Occurrence Handle1:CAS:528:DC%2BD2MXis1Kisrg%3D Occurrence Handle10.1002/jgm.659

    Article  PubMed  CAS  Google Scholar 

  157. Y. Zhang Y. F. Zhang J. Bryant A. Charles R. J. Boado W. M. Pardridge (2004) ArticleTitleIntravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer Clin. Cancer Res. 10 3667–3677 Occurrence Handle15173073 Occurrence Handle1:CAS:528:DC%2BD2cXksVKnsbg%3D Occurrence Handle10.1158/1078-0432.CCR-03-0740

    Article  PubMed  CAS  Google Scholar 

  158. World Health Organisation. Number of Confirmed Cases of Poliomyelitis 2002–2005 (as of 12 September 2005), http://www.emro.who.int/polio/ (accessed 16 September 2005), part of http://www.who.int (accessed 16 September 2005).

  159. World Health Organisation. Smallpox, http://www.who.int/topics/smallpox/en/ (accessed 16 September 2005), part of http://www.who.int (accessed 16 September 2005).

  160. S. Maesaki (2002) ArticleTitleDrug delivery system of anti-fungal and parasitic agents Curr. Pharm. Des. 8 433–440 Occurrence Handle12069380 Occurrence Handle1:CAS:528:DC%2BD38Xis1Omtrk%3D Occurrence Handle10.2174/1381612023395916

    Article  PubMed  CAS  Google Scholar 

  161. B. Dupont (2002) ArticleTitleOverview of the lipid formulations of amphothericin B J. Antimicrob. Chemother. 49 31–36 Occurrence Handle11801578 Occurrence Handle1:CAS:528:DC%2BD38XhsFChtbw%3D Occurrence Handle10.1093/jac/49.1.31

    Article  PubMed  CAS  Google Scholar 

  162. O. Ringden (2002) ArticleTitleTen years' experience with liposomal amphotericin B in transplant recipients at Huddinge University Hospital J. Antimicrob. Chemother. 49 51–55 Occurrence Handle11801582 Occurrence Handle1:CAS:528:DC%2BD38XhsFChtbg%3D

    PubMed  CAS  Google Scholar 

  163. S. L. Croft G. H. Coombs (2003) ArticleTitleLeishmaniasis-current chemotherapy and recent advances in the search for novel drugs Trends Parasitol. 19 502–508 Occurrence Handle14580961 Occurrence Handle1:CAS:528:DC%2BD3sXosVyisL0%3D Occurrence Handle10.1016/j.pt.2003.09.008

    Article  PubMed  CAS  Google Scholar 

  164. A. W. K. Ng K. M. Wasan (2003) ArticleTitleDevelopment of liposomal polyene antibiotics: an historical perspective J. Pharm. Pharm. Sci. 6 67–83 Occurrence Handle12753730 Occurrence Handle1:CAS:528:DC%2BD3sXjvVGhsbk%3D

    PubMed  CAS  Google Scholar 

  165. W. J. Gibbs R. H. Drew J. R. Perfect (2005) ArticleTitleLiposomal amphotericin B: clinical experience and perspectives Expert Rev. Anti-infect. Ther. 3 167–181 Occurrence Handle15918775 Occurrence Handle1:CAS:528:DC%2BD2MXjt1ymurg%3D Occurrence Handle10.1586/14787210.3.2.167

    Article  PubMed  CAS  Google Scholar 

  166. M. Owais G. C. Varshney A. Choudhury S. Chandra C. M. Gupta (1995) ArticleTitleChloroquine encapsulated in malaria-infected erythrocyte-specific antibody-bearing liposomes effectively controls chloroquine-resistant Plasmodium berghei infections in mice Antimicrob. Agents. Chemother. 39 180–184 Occurrence Handle7695303 Occurrence Handle1:CAS:528:DyaK2MXislKksbw%3D

    PubMed  CAS  Google Scholar 

  167. J. P. Adler-Moore R. T. Proffitt (1993) ArticleTitleDevelopment, characterization, efficacy and mode of action of Ambisome®, a unilamellar liposome formulation of amphotericin B J. Liposome Res. 3 429–450 Occurrence Handle1:CAS:528:DyaK2cXit1Klsrk%3D

    CAS  Google Scholar 

  168. H. W. Murray (2004) ArticleTitleProgress in the treatment of a neglected infectious disease: visceral leishmaniasis Expert Rev. Anti-infect. Ther. 2 279–292 Occurrence Handle15482193 Occurrence Handle1:CAS:528:DC%2BD2cXislyqsr4%3D Occurrence Handle10.1586/14787210.2.2.279

    Article  PubMed  CAS  Google Scholar 

  169. H. W. Murray (2004) ArticleTitleTreatment of visceral leishmaniasis in 2004 Am. J. Trop. Med. Hyg. 71 787–794 Occurrence Handle15642973

    PubMed  Google Scholar 

  170. M. Larabi V. Yardley P. M. Loiseau M. Appel P. Legrand A. Gulik C. Boris S. Croft G. Barratt (2003) ArticleTitleToxicity and antileishmanial activity of a new stable lipid suspension of amphothericin B Antimicrob. Agents Chemother. 47 3774–3779 Occurrence Handle14638481 Occurrence Handle1:CAS:528:DC%2BD3sXpsV2ntbw%3D Occurrence Handle10.1128/AAC.47.12.3774-3779.2003

    Article  PubMed  CAS  Google Scholar 

  171. M. K. Basu S. Lala (2004) ArticleTitleMacrophage specific drug delivery in experimental leishmaniasis Curr. Mol. Med. 4 681–689 Occurrence Handle15357216 Occurrence Handle1:CAS:528:DC%2BD2cXmvVKmt70%3D Occurrence Handle10.2174/1566524043360186

    Article  PubMed  CAS  Google Scholar 

  172. P. Legrand G. Barratt V. Mosqueira H. Fessi J. P. Devissaguet (1999) ArticleTitlePolymeric nanocapsules as drug delivery systems: a review Sci. Tech. Pharm. 9 411–418 Occurrence Handle1:CAS:528:DC%2BD3cXjsF2jsg%3D%3D

    CAS  Google Scholar 

  173. R. Gaspar V. Preat F. R. Opperdoes M. Rolland (1992) ArticleTitleMacrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: activity against intracellular Leishmania donovani associated with hydrogen peroxide production Pharm. Res. 9 782–787 Occurrence Handle1409361 Occurrence Handle1:CAS:528:DyaK38Xktlemuro%3D Occurrence Handle10.1023/A:1015807706530

    Article  PubMed  CAS  Google Scholar 

  174. M. Fouarge M. Dewulf P. Couvreur M. Rolland H. Vranckx (1989) ArticleTitleDevelopment of dehydroemetine nanoparticles for the treatment of visceral leishmaniasis J. Microencapsul. 6 29–34 Occurrence Handle2565955 Occurrence Handle1:CAS:528:DyaL1MXhs1Sgsb4%3D

    PubMed  CAS  Google Scholar 

  175. M. S. Espuelas P. Legrand M. A. Campanero M. Appel M. Chéron C. Gamazo G. Barratt J. M. Irache (2003) ArticleTitlePolymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice J. Antimicrob. Chemother. 52 419–427 Occurrence Handle12888593 Occurrence Handle1:CAS:528:DC%2BD3sXnt1Kjt7Y%3D Occurrence Handle10.1093/jac/dkg351

    Article  PubMed  CAS  Google Scholar 

  176. R. Tyagi S. Lala A. K. Verma A. K. Nandy S. B. Mahato A. Maitra M. K. Basu (2005) ArticleTitleTargeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis J. Drug Target. 13 161–171 Occurrence Handle16036304 Occurrence Handle1:CAS:528:DC%2BD2MXjvFajsb0%3D

    PubMed  CAS  Google Scholar 

  177. V. C. F. Mosqueira P. M. Loiseau C. Bories P. Legrand J. P. Devissaguet G. Barratt (2004) ArticleTitleEfficacy and pharmacokinetics of intravenous nanocapsule formulations of halofantrine in Plasmodium berghei-infected mice Antimicrob. Agents Chemother. 48 1222–1228 Occurrence Handle15047523 Occurrence Handle1:CAS:528:DC%2BD2cXjtVKqsr4%3D Occurrence Handle10.1128/AAC.48.4.1222-1228.2004

    Article  PubMed  CAS  Google Scholar 

  178. I. A. Bakker-Woudenberg (2002) ArticleTitleLong-circulating sterically stabilized liposomes as carriers of agents for treatment of infection or for imaging infectious foci Int. J. Antimicrob. Agents 19 299–311 Occurrence Handle11978501 Occurrence Handle1:CAS:528:DC%2BD38XjtVeisL0%3D Occurrence Handle10.1016/S0924-8579(02)00021-3

    Article  PubMed  CAS  Google Scholar 

  179. H. Pinto-Alphandary A. Andremont P. Couvreur (2000) ArticleTitleTargeted delivery of antibiotics using liposomes and nanoparticles: research and applications Int. J. Antimicrob. Agents 13 155–168 Occurrence Handle10724019 Occurrence Handle1:CAS:528:DyaK1MXns1Whur0%3D Occurrence Handle10.1016/S0924-8579(99)00121-1

    Article  PubMed  CAS  Google Scholar 

  180. R. Schiffelers G. Storm I. Bakker-Woudenberg (2001) ArticleTitleLiposome-encapsulated aminoglycosides in pre-clinical and clinical studies J. Antimicrob. Chemother. 48 333–344 Occurrence Handle11532996 Occurrence Handle1:CAS:528:DC%2BD3MXntlSgtL8%3D Occurrence Handle10.1093/jac/48.3.333

    Article  PubMed  CAS  Google Scholar 

  181. G. Barratt (2004) ArticleTitleColloidal drug carriers: achievements and perspectives Cell. Mol. Life Sci. 60 21–37 Occurrence Handle10.1007/s000180300002

    Article  Google Scholar 

  182. R. M. Fielding R. O. Lewis L. Moon-McDermott (1998) ArticleTitleAltered tissue distribution and elimination of Amikacin encapsulated in unilamellar, low clearance liposomes (Mikasome®) Pharm. Res. 15 1775–1781 Occurrence Handle9834002 Occurrence Handle1:CAS:528:DyaK1cXnsFSns7Y%3D Occurrence Handle10.1023/A:1011925132473

    Article  PubMed  CAS  Google Scholar 

  183. R. M. Fielding L. Moon-McDermott R. O. Lewis M. J. Horner (1999) ArticleTitlePharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after a single or repeated intravenous administration in the rhesus monkey Antimicrob. Agents Chemother. 43 503–509 Occurrence Handle10049258 Occurrence Handle1:CAS:528:DyaK1MXhsF2htLo%3D Occurrence Handle10.1093/jac/43.4.503

    Article  PubMed  CAS  Google Scholar 

  184. P. R. Donald F. A. Sirgel A. Venter E. Smit D. P. Parkin B. W. Wal ParticleVan de D. A. Mitchison (2001) ArticleTitleThe early bactericidal activity of a low-clearance liposomal amikacin in pulmonary tuberculosis J. Antimicrob. Chemother. 48 877–880 Occurrence Handle11733472 Occurrence Handle1:CAS:528:DC%2BD38Xjt1eitA%3D%3D Occurrence Handle10.1093/jac/48.6.877

    Article  PubMed  CAS  Google Scholar 

  185. E. Fattal M. Youssef P. Couvreur A. Andremont (1989) ArticleTitleTreatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles Antimicrob. Agents Chemother. 33 1540–1543 Occurrence Handle2684009 Occurrence Handle1:CAS:528:DyaL1MXlvVSmurk%3D

    PubMed  CAS  Google Scholar 

  186. E. Fattal J. Rojas M. Youssef P. Couvreur A. Andremont (1991) ArticleTitleLiposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salmonellosis Antimicrob. Agents Chemother. 35 770–772 Occurrence Handle2069386 Occurrence Handle1:CAS:528:DyaK3MXitFCgsr8%3D

    PubMed  CAS  Google Scholar 

  187. E. Fattal O. Balland H. Alphandary S. Pecquet F. Puisieux P. Couvreur A. Andremont (1993) Colloidal carriers of antibiotics as an alternative approach for the treatment of intracellular infections D. Raoult (Eds) Antimicrobial Agents and Intracellular Pathogens CRC Press Boca Raton, FL 63–72

    Google Scholar 

  188. M. Yousseff E. Fattal M. J. Alonso L. Roblot-Treupel J. Sauzières C. Tancrède A. Omnes P. Couvreur A. Andremont (1988) ArticleTitleEffectiveness of nanoparticle-bound ampicillin in the treatment of Listeria monocytogenes infection in athymic nude mice Antimicrob. Agents Chemother. 32 1204–1207

    Google Scholar 

  189. M. E. Page-Clisson H. Pinto-Alphandary E. Chachaty P. Couvreur A. Andremont (1998) ArticleTitleDrug targeting by polyalkylcyanoacrylate is not efficient against persistent Salmonella Pharm. Res. 15 542–547

    Google Scholar 

  190. Y. Zhang (2005) ArticleTitleThe magic bullets and tuberculosis targets Annu. Rev. Pharmacol. Toxicol. 45 529–564 Occurrence Handle15822188 Occurrence Handle1:CAS:528:DC%2BD2MXisVWjtLg%3D Occurrence Handle10.1146/annurev.pharmtox.45.120403.100120

    Article  PubMed  CAS  Google Scholar 

  191. A. I. Vitas R. Diaz C. Gamazo (1996) ArticleTitleEffect on composition and method of preparation of liposomes on their stability and interaction with murine monocytes infected with Brucella abortus Antimicrob. Agents Chemother. 40 146–151 Occurrence Handle8787896 Occurrence Handle1:CAS:528:DyaK28XhvFOitQ%3D%3D

    PubMed  CAS  Google Scholar 

  192. A. Engel S. Kumar Chatterjee A. Al-Arifi D. Riemann J. Laugner P. Nuhn (2003) ArticleTitleInfluence of spacer length in interaction of mannosylated liposomes with human phagocytic cells Pharm. Res. 20 51–57 Occurrence Handle12608536 Occurrence Handle1:CAS:528:DC%2BD3sXoslKhsA%3D%3D Occurrence Handle10.1023/A:1022294624256

    Article  PubMed  CAS  Google Scholar 

  193. K. E. Anderson L. A. Eliot B. R. Stevenson J. A. Rogers (2001) ArticleTitleFormulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form Pharm. Res. 18 316–322 Occurrence Handle11442271 Occurrence Handle1:CAS:528:DC%2BD3MXltVSksbo%3D Occurrence Handle10.1023/A:1011002913601

    Article  PubMed  CAS  Google Scholar 

  194. C. I. Price J. W. Horton C. R. Baxter (1994) ArticleTitleLiposome encapsulation: a method for enhancing the effectiveness of local antibiotics Surgery 115 480–487 Occurrence Handle8165539 Occurrence Handle1:STN:280:DyaK2c3hvVOqsw%3D%3D

    PubMed  CAS  Google Scholar 

  195. N. M. Sanderson M. N. Jones (1996) ArticleTitleEncapsulation of vancomycin and gentamicin within cationic liposomes for inhibition of growth of Staphylococcus epidermidis J. Drug Target. 4 181–189 Occurrence Handle8959490 Occurrence Handle1:CAS:528:DyaK28XntVGnt7c%3D

    PubMed  CAS  Google Scholar 

  196. J. Frucht-Perry K. K. Assil E. Ziegler H. Douglas S. I. Brown D. J. Schanzlin R. N. Weinreb (1992) ArticleTitleFibrin-enmeshed tobramycin liposomes: single application topical therapy of Pseudomonas keratitis Cornea 11 393–397 Occurrence Handle1424666 Occurrence Handle1:STN:280:DyaK3s%2FkvVSjsA%3D%3D

    PubMed  CAS  Google Scholar 

  197. J. Conley H. Yang T. Wilson K. Blasetti V. Ninno ParticleDi G. Schnell J. Park Wong (1997) ArticleTitleAerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice Antimicrob. Agents Chemother. 41 1288–1292 Occurrence Handle9174185 Occurrence Handle1:CAS:528:DyaK2sXjsFCgtL8%3D

    PubMed  CAS  Google Scholar 

  198. J. P. Wong H. Yang K. L. Blasetti G. Schnell J. Conley L. N. Schofield (2003) ArticleTitleLiposome delivery of ciprofloxacin against intracellular Francisella tularensis infection J. Control. Release 92 265–273 Occurrence Handle14568408 Occurrence Handle1:CAS:528:DC%2BD3sXot1SrsLo%3D Occurrence Handle10.1016/S0168-3659(03)00358-4

    Article  PubMed  CAS  Google Scholar 

  199. M. A. Rauschmann T. A. Wichelhous V. Stirnal E. Dingeldein L. Zichner R. Schnettle V. Alt (2005) ArticleTitleNanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections Biomaterials 26 2677–2684 Occurrence Handle15585271 Occurrence Handle1:CAS:528:DC%2BD2cXhtVChsrrK Occurrence Handle10.1016/j.biomaterials.2004.06.045

    Article  PubMed  CAS  Google Scholar 

  200. D. Jikia N. Chkhaidze E. Imedashvili I. Mgaloblishvili G. Tsitlanadze R. Katsarava J. Glenn Morris A. Sulakvelidze (2005) ArticleTitleThe use if a novel biodegradable preparation capable of the sustained release of bacteriophages and ciprofloxacin, in the complex treatment of multidrug-resistant Staphylococcus aureus-infection local radiation injuries caused by exposure to Sr 90 Clin. Exp. Dermatol. 30 23–26 Occurrence Handle15663496 Occurrence Handle1:STN:280:DC%2BD2M%2Fjs12mtQ%3D%3D Occurrence Handle10.1111/j.1365-2230.2004.01600.x

    Article  PubMed  CAS  Google Scholar 

  201. J. Wang B. Hu M. Xu Q. Yan S. Liu X. Zhu Z. Sun D. Tao L. Ding E. Reed J. Gong Q. Q. Li J. Hu (2006) ArticleTitleTherapeutic effectiveness of bacteriophages in the rescue of mice with extended spectrum beta-lactamase-producing Escherichia coli bacteremia Int. J. Mol. Med. 17 347–355 Occurrence Handle16391836

    PubMed  Google Scholar 

  202. J. Wang B. Hu M. Xu Q. Yan S. Liu X. Zhu Z. Sun E. Reed L. Ding J. Gong Q. Q. Li J. Hu (2006) ArticleTitleUse of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa Int. J. Mol. Med. 17 309–317 Occurrence Handle16391831

    PubMed  Google Scholar 

  203. D. A. Putnam (1996) ArticleTitleAntisense strategies and therapeutic applications Am. J. Health-Syst. Pharm. 52 151–160

    Google Scholar 

  204. N. Duzgunes E. Pretzer S. Simoes V. Slepushkin K. Konopka D. Flasher M. C. Pedroso de Lima (1999) ArticleTitleLiposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells Mol. Membr. Biol. 16 111–118 Occurrence Handle10332745 Occurrence Handle1:CAS:528:DyaK1MXis1Ggsr4%3D Occurrence Handle10.1080/096876899294832

    Article  PubMed  CAS  Google Scholar 

  205. C. Martinand-Mari B. Lebleu I. Robbins (2003) ArticleTitleOligonucleotide-based strategies to inhibit human hepatitis C virus Oligonucleotides 13 348–539 Occurrence Handle10.1089/154545703322860834 Occurrence Handle1:CAS:528:DC%2BD2cXhs12kurs%3D

    Article  CAS  Google Scholar 

  206. V. Nair (2003) ArticleTitleNovel inhibitors of HIV integrase: the discovery of potential anti-HIV therapeutic agents Curr. Pharm. Des. 9 2553–2565 Occurrence Handle14529542 Occurrence Handle1:CAS:528:DC%2BD3sXpsVCktL0%3D Occurrence Handle10.2174/1381612033453703

    Article  PubMed  CAS  Google Scholar 

  207. K. Maggon S. Barik (2004) ArticleTitleNew drugs and treatment for respiratory syncytial virus Rev. Med. Virol. 14 149–168 Occurrence Handle15124232 Occurrence Handle1:CAS:528:DC%2BD2cXltFOlt7o%3D Occurrence Handle10.1002/rmv.423

    Article  PubMed  CAS  Google Scholar 

  208. J. M. Irache M. Merodio A. Arnedo M. A. Camapanero M. Mirchahi S. Espuelas (2005) ArticleTitleAlbumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs Mini Rev. Med. Chem. 5 293–305 Occurrence Handle15777263 Occurrence Handle1:CAS:528:DC%2BD2MXhvVCgt74%3D

    PubMed  CAS  Google Scholar 

  209. M. Markosian R. M. Hyde (2005) ArticleTitleOligonucleotides and polyribonucleotides: a review of antiviral activity Antivir. Chem. Chemother. 16 91–102 Occurrence Handle15889532 Occurrence Handle1:CAS:528:DC%2BD2MXktlanu78%3D

    PubMed  CAS  Google Scholar 

  210. N. Duzgunes S. Simoes V. Slepushkin E. Pretzer E. Clerq ParticleDe V. P. Antao M. L. Collins M. C. Pedroso de Lima (2001) ArticleTitleEnhanced inhibition of HIV-1 replication in macrophages by antisense oligonucleotides, ribozymes and acyclic nucleoside phosphonate analogs delivered in pH sensitive liposomes Nucleosides Nucleotides Nucleic Acids 20 515–523 Occurrence Handle11563068 Occurrence Handle1:CAS:528:DC%2BD3MXmslCqs7Y%3D Occurrence Handle10.1081/NCN-100002327

    Article  PubMed  CAS  Google Scholar 

  211. A. M. Harandi (2004) ArticleTitleThe potential of immunostimulatory CpG DNA for inducing immunity against genital herpes: opportunities and challenges J. Clin. Virol. 30 207–210 Occurrence Handle15135735 Occurrence Handle1:CAS:528:DC%2BD2cXjvVanur8%3D

    PubMed  CAS  Google Scholar 

  212. G. K. Mutwiri A. K. Nichano S. Babiuk L. A. Babiuk (2004) ArticleTitleStrategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides J. Control. Release 97 1–17 Occurrence Handle15147800 Occurrence Handle1:CAS:528:DC%2BD2cXjvFOntr8%3D Occurrence Handle10.1016/j.jconrel.2004.02.022

    Article  PubMed  CAS  Google Scholar 

  213. D. Trabattoni A. Clivio D. H. Bray L. Bhagat S. Beltrami G. Maffeis R. Cesana P. Lowry F. Lissoni E. R. Kandimalla T. Sullivan S. Agrawal R. Bartholomew M. Clerici (2006) ArticleTitleImmunization with gp120-depleted whole killed HIV immunogen and a second-generation CpG DNA elicits strong HIV-specific responses in mice Vaccine 24 1470–1477 Occurrence Handle16221513 Occurrence Handle1:CAS:528:DC%2BD28Xhs1Smt7c%3D Occurrence Handle10.1016/j.vaccine.2005.05.047

    Article  PubMed  CAS  Google Scholar 

  214. A. Bochot P. Couvreur E. Fattal (2000) ArticleTitleIntravitreal administration of antisense oligonucleotides: potential of liposomal delivery Prog. Retin. Eye Res. 19 131–147 Occurrence Handle10674705 Occurrence Handle1:CAS:528:DC%2BD3cXhtFaruro%3D Occurrence Handle10.1016/S1350-9462(99)00014-2

    Article  PubMed  CAS  Google Scholar 

  215. A. Arnedo J. M. Irache M. Merodio M. S. Espuelas Millan (2004) ArticleTitleAlbumin nanoparticles improved the stability, nuclear accumulation and anticytomegaloviral activity of a phosphodiester oligonucleotide J. Control. Release 94 217–227 Occurrence Handle14684285 Occurrence Handle1:CAS:528:DC%2BD3sXpslClsbY%3D Occurrence Handle10.1016/j.jconrel.2003.10.009

    Article  PubMed  CAS  Google Scholar 

  216. A. Bochot E. Fattal V. Boutet J. R. Deverre J. C. Jeanny H. Chacun P. Couvreur (2002) ArticleTitleIntravitreal delivery of oligonucleotides by sterically stabilized liposomes Investig. Ophtalmol. Vis. Sci. 43 253–259

    Google Scholar 

  217. E. Fattal G. Rosa ParticleDe A. Bochot (2004) ArticleTitleGel and solid matrix systems for the controlled delivery of drug carrier-associated nucleic acids Int. J. Pharm. 277 25–30 Occurrence Handle15158966 Occurrence Handle1:CAS:528:DC%2BD2cXktFOisL0%3D Occurrence Handle10.1016/j.ijpharm.2003.01.002

    Article  PubMed  CAS  Google Scholar 

  218. F. Shi D. Hoekstra (2004) ArticleTitleEffective intracellular delivery of oligonucleotides in order to make sense of antisense J. Control. Release 97 189–209 Occurrence Handle15196747 Occurrence Handle1:CAS:528:DC%2BD2cXkslKmtLY%3D Occurrence Handle10.1016/j.jconrel.2004.03.016

    Article  PubMed  CAS  Google Scholar 

  219. C. Ropert M. Lavigno C. Dubernet P. Couvreur C. Malvy (1992) ArticleTitleOligonucleotides encapsulated in pH-sensitive liposomes are efficient toward Friend retrovirus Biochem. Biophys. Res. Commun. 183 879–885 Occurrence Handle1550594 Occurrence Handle1:CAS:528:DyaK38XitVSqtbs%3D Occurrence Handle10.1016/0006-291X(92)90565-3

    Article  PubMed  CAS  Google Scholar 

  220. C. Ropert C. Malvy P. Couvreur (1993) ArticleTitleInhibition of the Friend retrovirus by antisense oligonucleotides encapsulated in liposomes: mechanism of action Pharm. Res. 10 1427–1433 Occurrence Handle8272403 Occurrence Handle1:CAS:528:DyaK3sXmslyntLc%3D Occurrence Handle10.1023/A:1018910922633

    Article  PubMed  CAS  Google Scholar 

  221. C. Ropert Z. Mishal SuffixJr. J. M. Rodrigues C. Malvy P. Couvreur (1996) ArticleTitleRetrovirus budding may contribute a port of entry for drug carriers Biochim. Biophys. Acta 1310 53–59 Occurrence Handle9244175 Occurrence Handle10.1016/0167-4889(95)00140-9

    Article  PubMed  Google Scholar 

  222. M. Berton P. Turelli D. Trono C. A. Stein E. Allemann R. Gurny (2001) ArticleTitleInhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles Pharm. Res. 18 1096–1101 Occurrence Handle11587479 Occurrence Handle1:CAS:528:DC%2BD3MXnt1ektrk%3D Occurrence Handle10.1023/A:1010962507273

    Article  PubMed  CAS  Google Scholar 

  223. A. Zimmer (1999) ArticleTitleAntisense oligonucleotides delivery with polyhexylcyanoacrylate nanoparticles as carriers Methods 18 286–295 Occurrence Handle10454987 Occurrence Handle1:CAS:528:DyaK1MXltFKkurs%3D Occurrence Handle10.1006/meth.1999.0786

    Article  PubMed  CAS  Google Scholar 

  224. G. Lambert E. Fattal P. Couvreur (2001) ArticleTitleNanoparticulate systems for the delivery of antisense oligonucleotides Adv. Drug Deliv. Rev. 47 99–112 Occurrence Handle11251248 Occurrence Handle1:CAS:528:DC%2BD3MXhvVajsrc%3D Occurrence Handle10.1016/S0169-409X(00)00116-2

    Article  PubMed  CAS  Google Scholar 

  225. V. Vogel D. Lochmann J. Weyermann G. Mayer C. Tziatzios J. A. Broek ParticleVan den W. Haase D. Wouters U. S. Schubert J. Kreuter A. Zimmer D. Schubert (2005) ArticleTitleOligonucleotide–protamine–albumin nanoparticles: preparation, physical properties, and intracellular distribution J. Control. Release 103 99–111 Occurrence Handle15710504 Occurrence Handle1:CAS:528:DC%2BD2MXhtlequrs%3D Occurrence Handle10.1016/j.jconrel.2004.11.029

    Article  PubMed  CAS  Google Scholar 

  226. Q. Hu C. R. Shew M. B. Bally T. D. Madden (2001) ArticleTitleProgrammable fusogenic vesicles for intracellular delivery of antisense oligodeoxynucleotides: enhanced cellular uptake and biological effects Biochim. Biophys. Acta 1514 1–13 Occurrence Handle11513800 Occurrence Handle1:CAS:528:DC%2BD3MXmtFWjt7k%3D Occurrence Handle10.1016/S0005-2736(01)00294-2

    Article  PubMed  CAS  Google Scholar 

  227. J. Kunizawa T. Masuda K. Katayama T. Yoshikawa Y. Tsutsumi M. Akashi T. Mayumi S. Nakagawa (2005) ArticleTitleFusogenic liposome delivers encapsulated nanoparticles for cytosolic controlled gene release J. Control. Release 105 344–353 Occurrence Handle10.1016/j.jconrel.2005.03.020 Occurrence Handle1:CAS:528:DC%2BD2MXlvVyrtbw%3D

    Article  CAS  Google Scholar 

  228. A. Dembri M. J. Montisci J. C. Gantier H. Chacun G. Ponchel (2001) ArticleTitleTargeting of 3′-azido 3′-deoxythymidine (AZT)-loaded poly(isohexylcyanoacrylate) nanospheres to the gastrointestinal mucosa and associated lymphoid tissues Pharm. Res. 18 467–473 Occurrence Handle11451033 Occurrence Handle1:CAS:528:DC%2BD3MXkvFCnsrY%3D Occurrence Handle10.1023/A:1011050209986

    Article  PubMed  CAS  Google Scholar 

  229. H. Boudad P. Legrand M. Appel M. H. Coconier G. Ponchel (2001) ArticleTitleFormulation and cytotoxicity of combined cyclodextrin poly(alkylcyanoacrylate) nanoparticles on Caco-2 cells monolayers intended for oral administration of saquinavir STP Pharm. Sci. 11 369–375 Occurrence Handle1:CAS:528:DC%2BD38XovVKltw%3D%3D

    CAS  Google Scholar 

  230. A. R. Bender H. Briesen ParticleVon J. Kreuter I. B. Duncan H. Rubasmen-Waigmann (1996) ArticleTitleEfficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro Antimicrob. Agents Chemother. 40 1467–1471 Occurrence Handle8726020 Occurrence Handle1:CAS:528:DyaK28XjtlWmtbw%3D

    PubMed  CAS  Google Scholar 

  231. F. Jaeghere ParticleDe E. Allemann F. Kubel B. Galli R. Cozens E. Doelker R. Gurny (2000) ArticleTitleOral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state J. Control. Release 68 291–298 Occurrence Handle10925137 Occurrence Handle10.1016/S0168-3659(00)00272-8

    Article  PubMed  Google Scholar 

  232. M. Meridio J. M. Irache F. Valamanesh M. Mirshahi (2002) ArticleTitleOcular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats Biomaterials 23 1587–1594 Occurrence Handle10.1016/S0142-9612(01)00284-8

    Article  Google Scholar 

  233. M. Fresta G. Fontana C. Bucolo G. Cavallo G. Giammona G. Puglisi (2001) ArticleTitleOcular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir J. Pharm. Sci. 9 288–297 Occurrence Handle10.1002/1520-6017(200103)90:3<288::AID-JPS4>3.0.CO;2-5

    Article  Google Scholar 

  234. S. C. Sookoian (2003) ArticleTitleNew therapies on the horizon for hepatitis C Ann. Hepatol. 2 164–170 Occurrence Handle15115955

    PubMed  Google Scholar 

  235. G. V. Papatheodorodis E. Cholongitas (2004) ArticleTitleChronic hepatitis C and no response to antiviral therapy: potential current and future therapeutic options J. Viral Hepatitis 11 287–296 Occurrence Handle10.1111/j.1365-2893.2004.00522.x

    Article  Google Scholar 

  236. M. L. Shiffman (2004) ArticleTitleRetreatment of patients who do not respond to initial therapy for chronic hepatitis C Clevel. Clin. J. Med. 71 S13–S16 Occurrence Handle10.3949/ccjm.71.Suppl_3.S13

    Article  Google Scholar 

  237. M. Singh D. T. O'Hagan (2002) ArticleTitleRecent advances in vaccine adjuvants Pharm. Res. 19 715–728 Occurrence Handle12134940 Occurrence Handle1:CAS:528:DC%2BD38XltVSgsLs%3D Occurrence Handle10.1023/A:1016104910582

    Article  PubMed  CAS  Google Scholar 

  238. J. A. Berzofsky J. D. Ahlers J. Janik J. Morris S. Oh M. Tarabe I. M. Belyakov (2004) ArticleTitleProgress on new vaccine strategies against chronic viral infections J. Clin. Invest. 114 450–462 Occurrence Handle15314679 Occurrence Handle1:CAS:528:DC%2BD2cXmvVemu70%3D Occurrence Handle10.1172/JCI200422674

    Article  PubMed  CAS  Google Scholar 

  239. D. T. O'Hagan R. Rappuoli (2004) ArticleTitleNovel approaches to vaccine delivery Pharm. Res. 21 1519–1530 Occurrence Handle15497674 Occurrence Handle10.1023/B:PHAM.0000041443.17935.33

    Article  PubMed  Google Scholar 

  240. M. Vajdy I. Srivastava J. Polo J. Donnelly D. O'Hagan M. Singh (2004) ArticleTitleMucosal adjuvants and delivery systems for protein-,DNA- and RNA-based vaccines Immunol. Cell Biol. 82 616–627 Occurrence Handle10.1111/j.1440-1711.2004.01288.x Occurrence Handle1:CAS:528:DC%2BD2cXhtFakur%2FP

    Article  CAS  Google Scholar 

  241. J. Kreuter (1995) ArticleTitleNanoparticles as adjuvants for vaccines Pharm. Biotechnol. 6 463–472 Occurrence Handle7551231 Occurrence Handle1:CAS:528:DyaK2MXpsFGrsrw%3D

    PubMed  CAS  Google Scholar 

  242. Z. H. Jiang R. R. Koganty (2003) ArticleTitleSynthetic vaccines: the role of adjuvants in immune targeting Curr. Med. Chem. 10 1423–1439 Occurrence Handle12871139 Occurrence Handle1:CAS:528:DC%2BD3sXls1Wrtbc%3D Occurrence Handle10.2174/0929867033457340

    Article  PubMed  CAS  Google Scholar 

  243. C. Moser I. C. Metcalfe J. F. Viret (2003) ArticleTitleVirosomal adjuvanted antigen delivery systems Expert Rev. Vaccines 2 189–196 Occurrence Handle12899570 Occurrence Handle1:CAS:528:DC%2BD3sXjsVOksL4%3D Occurrence Handle10.1586/14760584.2.2.189

    Article  PubMed  CAS  Google Scholar 

  244. L. Leserman (2004) ArticleTitleLiposomes as protein carriers in immunology J. Liposome Res. 14 175–189 Occurrence Handle15676125 Occurrence Handle1:CAS:528:DC%2BD2cXhtVCisbjJ Occurrence Handle10.1081/LPR-200039198

    Article  PubMed  CAS  Google Scholar 

  245. M. J. Copland T. Rades N. M. Davies M. A. Baird (2005) ArticleTitleLipid based particulate formulations for the delivery of antigens Immunol. Cell Biol. 83 97–105 Occurrence Handle15748206 Occurrence Handle1:CAS:528:DC%2BD2MXjsV2qsro%3D Occurrence Handle10.1111/j.1440-1711.2005.01315.x

    Article  PubMed  CAS  Google Scholar 

  246. A. Huckriede L. Bungener T. Stegmann T. Daemen J. Medema A. M. Palache J. Wilschut (2005) ArticleTitleThe virosome concept for influenza vaccines Vaccine 23S1 S1/26–S1/38

    Google Scholar 

  247. N. Westerfeld R. Zurbriggen (2005) ArticleTitlePeptides delivered by immunostimulating reconstituted influenza virosomes J. Pept. Sci. 11 707–712 Occurrence Handle16059967 Occurrence Handle1:CAS:528:DC%2BD2MXht1ehtL%2FN Occurrence Handle10.1002/psc.700

    Article  PubMed  CAS  Google Scholar 

  248. J. Kreuter P. Speiser (1976) ArticleTitleIn vitro studies of poly(methylmethacrylate) adjuvants J. Pharm. Sci. 65 1624–1627 Occurrence Handle993993 Occurrence Handle1:CAS:528:DyaE2sXitFOgtw%3D%3D

    PubMed  CAS  Google Scholar 

  249. G. Gregoriadis (1994) ArticleTitleThe immunological adjuvant and vaccine carrier properties of liposomes J. Drug Target. 2 351–356 Occurrence Handle7704478 Occurrence Handle1:CAS:528:DyaK2MXjtVChsbc%3D

    PubMed  CAS  Google Scholar 

  250. J. Aucouturier L. Dupuis V. Ganne (2001) ArticleTitleAdjuvants designed for veterinary and human vaccines Vaccine 19 2666–2672 Occurrence Handle11257407 Occurrence Handle1:CAS:528:DC%2BD3MXitVOitrY%3D Occurrence Handle10.1016/S0264-410X(00)00498-9

    Article  PubMed  CAS  Google Scholar 

  251. T. Daemen L. Bungener A. Huckriede J. Wilschut (2000) ArticleTitleVirosomes as an antigen delivery system J. Liposome Res. 10 329–338 Occurrence Handle1:CAS:528:DC%2BD3MXlt1GktA%3D%3D

    CAS  Google Scholar 

  252. R. Glück I. C. Metcalfe (2002) ArticleTitleNew technology platforms in the development of vaccines for the future Vaccine 20 B10–B16 Occurrence Handle12477412 Occurrence Handle10.1016/S0264-410X(02)00513-3

    Article  PubMed  Google Scholar 

  253. S. Esposito P. Marchisio S. Bosis L. Lambertini L. Claut N. Faelli C. Bianchi G. L. Colombo N. Principi (2006) ArticleTitleClinical and economic impact of influenza vaccination on healthy children aged 2–5 years Vaccine 24 629–635 Occurrence Handle16157429 Occurrence Handle10.1016/j.vaccine.2006.03.059

    Article  PubMed  Google Scholar 

  254. R. Noad P. Roy (2003) ArticleTitleVirus-like particles as immunogens Trends Microbiol. 11 438–444 Occurrence Handle13678860 Occurrence Handle1:CAS:528:DC%2BD3sXnt1ylu70%3D Occurrence Handle10.1016/S0966-842X(03)00208-7

    Article  PubMed  CAS  Google Scholar 

  255. R. L. Garcea L. Gissmann (2004) ArticleTitleVirus-like particles as vaccines and vessels for the delivery of small molecules Curr. Opin. Biotechnol. 15 513–517 Occurrence Handle15560977 Occurrence Handle1:CAS:528:DC%2BD2cXhtVWjtrzM Occurrence Handle10.1016/j.copbio.2004.10.002

    Article  PubMed  CAS  Google Scholar 

  256. T. Storni C. Ruedl K. Schwarz R. A. Schwendener W. A. Renner M. F. Bachmann (2004) ArticleTitleNonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects J. Immunol. 172 1777–1785 Occurrence Handle14734761 Occurrence Handle1:CAS:528:DC%2BD2cXptl2hsg%3D%3D

    PubMed  CAS  Google Scholar 

  257. B. Morein K. F. Hu I. Abusugra (2004) ArticleTitleCurrent status and potential application of ISCOMs in veterinary medicine Adv. Drug Deliv. Rev. 56 1367–1382 Occurrence Handle15191787 Occurrence Handle1:CAS:528:DC%2BD2cXkvVCrt7g%3D Occurrence Handle10.1016/j.addr.2004.02.004

    Article  PubMed  CAS  Google Scholar 

  258. P. Hoegen ParticleVon (2001) ArticleTitleSynthetic biomimetic supra molecular Biovector™ (SMBV™) particles for nasal vaccine delivery Adv. Drug Deliv. Rev. 51 113–125 Occurrence Handle10.1016/S0169-409X(01)00175-2

    Article  Google Scholar 

  259. A. Debin R. Kravtzoff J. Santiago ParticleVaz L. Cazales S. Sperandio K. Melber Z. Janowicz D. Betbeder M. Moynier (2002) ArticleTitleIntranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses Vaccine 20 2752–2763 Occurrence Handle12034102 Occurrence Handle1:CAS:528:DC%2BD38XktVCrtbc%3D Occurrence Handle10.1016/S0264-410X(02)00191-3

    Article  PubMed  CAS  Google Scholar 

  260. B. C. Baudner O. Balland M. M. Guiliani P. Hoegen ParticleVon R. Rappuoli D. Betbeder G. Giudice ParticleDel (2002) ArticleTitleEnhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered nanoparticles Infect. Immun. 70 4785–4790 Occurrence Handle12183520 Occurrence Handle1:CAS:528:DC%2BD38Xmtl2itb0%3D Occurrence Handle10.1128/IAI.70.9.4785-4790.2002

    Article  PubMed  CAS  Google Scholar 

  261. T. Jung W. Kamm A. Breitenbach K. D. Hungerer E. Hundt T. Kissel (2001) ArticleTitleTetanus toxoid loaded nanoparticles from sulfobutylated poly(vinylalcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice Pharm. Res. 18 352–360 Occurrence Handle11442276 Occurrence Handle1:CAS:528:DC%2BD3MXltVSksbc%3D Occurrence Handle10.1023/A:1011063232257

    Article  PubMed  CAS  Google Scholar 

  262. M. Conacher J. Alexander J. M. Brewer (2001) ArticleTitleOral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes) Vaccine 19 2965–2974 Occurrence Handle11282208 Occurrence Handle1:CAS:528:DC%2BD3MXit1Wgtb0%3D Occurrence Handle10.1016/S0264-410X(00)00537-5

    Article  PubMed  CAS  Google Scholar 

  263. R. Gluck (2002) ArticleTitleIntranasal immunization against influenza J. Aerosol Med. 15 221–218 Occurrence Handle12184872 Occurrence Handle10.1089/089426802320282347

    Article  PubMed  Google Scholar 

  264. J. Holmgren C. Czerkinsky K. Erikssen A. Mharandi (2003) ArticleTitleMucosal immunisation and adjuvants: a brief overview of recent advances and challenges Vaccine 21 IssueID(Suppl 2) S89–S95 Occurrence Handle12763689 Occurrence Handle10.1016/S0264-410X(03)00206-8 Occurrence Handle1:CAS:528:DC%2BD3sXjvFWls7w%3D

    Article  PubMed  CAS  Google Scholar 

  265. J. Panyam V. Labhasetwar (2003) ArticleTitleBiodegradable nanoparticles for drug and gene delivery to cells and tissue Adv. Drug Deliv. Rev. 55 329–347 Occurrence Handle12628320 Occurrence Handle1:CAS:528:DC%2BD3sXhs1Cgurw%3D Occurrence Handle10.1016/S0169-409X(02)00228-4

    Article  PubMed  CAS  Google Scholar 

  266. M. Koping-Hoggard A. Sanchez M. J. Alonso (2005) ArticleTitleNanoparticles as carriers for nasal vaccine delivery Expert Rev. Vaccines 4 185–196 Occurrence Handle15889992 Occurrence Handle10.1586/14760584.4.2.185 Occurrence Handle1:CAS:528:DC%2BD2MXjt1yls7w%3D

    Article  PubMed  CAS  Google Scholar 

  267. A. T. Florence (1997) ArticleTitleThe oral absorption of micro- and nanoparticulates: neither exceptional nor unusual Pharm. Res. 14 259–266 Occurrence Handle9098866 Occurrence Handle1:CAS:528:DyaK2sXisVGlsro%3D Occurrence Handle10.1023/A:1012029517394

    Article  PubMed  CAS  Google Scholar 

  268. S. Mcclean F. Prosser F. Meehan D. O'Malley N. Clarke Z. Ramtoola D. Brayden (1998) ArticleTitleBinding and uptake of biodegradable poly-dl-lactide micro- and nanoparticles in intestinal epithelia Eur. J. Pharm. Sci. 6 153–163 Occurrence Handle9795038 Occurrence Handle1:CAS:528:DyaK1cXhsFejt7s%3D Occurrence Handle10.1016/S0928-0987(97)10007-0

    Article  PubMed  CAS  Google Scholar 

  269. T. Jung W. Kamm A. Breitenbach E. Kaiserling J. X. Xiao T. Kissel (2000) ArticleTitleBiodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur. J. Pharm. Biopharm. 50 147–160 Occurrence Handle10840198 Occurrence Handle1:CAS:528:DC%2BD3cXjslyisrs%3D Occurrence Handle10.1016/S0939-6411(00)00084-9

    Article  PubMed  CAS  Google Scholar 

  270. E. Fattal S. Pecquet P. Couvreur A. Andremont (2002) ArticleTitleBiodegradable microparticles for the mucosal delivery of antibacterial and dietary antigens Int. J. Pharm. 242 15–24 Occurrence Handle12176221 Occurrence Handle1:CAS:528:DC%2BD38Xmt1ygur4%3D Occurrence Handle10.1016/S0378-5173(02)00181-3

    Article  PubMed  CAS  Google Scholar 

  271. M. Shakweh M. Besnard V. Nicolas E. Fattal (2005) ArticleTitlePoly(lactide-co-glycolide) particles of different physicochemical properties and their uptake by Peyer's patches in mice Eur. J. Pharm. Biopharm. 61 1–13 Occurrence Handle16005619 Occurrence Handle1:CAS:528:DC%2BD2MXntVGjs7Y%3D Occurrence Handle10.1016/j.ejpb.2005.04.006

    Article  PubMed  CAS  Google Scholar 

  272. T. Fifis A. Gamvrellis B. Crimeen-Irwin G. A. Pietersz J. Li P. L. Mottram I. F. McKenzie M. Plebanski (2004) ArticleTitleSize-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors J. Immunol. 173 3148–3154 Occurrence Handle15322175 Occurrence Handle1:CAS:528:DC%2BD2cXmvVCqtrs%3D

    PubMed  CAS  Google Scholar 

  273. J. F. Mann V. A. Ferro A. B. Mullen L. Tetley M. Mullen K. C. Carter J. Alexander W. H. Stimson (2004) ArticleTitleOptimisation of a lipid based oral delivery system containing A/Panama influenza haemagglutinin Vaccine 22 2425–2429 Occurrence Handle15193405 Occurrence Handle1:CAS:528:DC%2BD2cXkvVemt7w%3D Occurrence Handle10.1016/j.vaccine.2003.11.067

    Article  PubMed  CAS  Google Scholar 

  274. U. Gluck J. O. Gebbers R. Gluck (1999) ArticleTitlePhase 1 evaluation of intranasal virosomal influenza vaccine with and without Escherichia coli heat-labile toxin in adult volunteers J. Virol. 73 7780–7786 Occurrence Handle10438868 Occurrence Handle1:CAS:528:DyaK1MXltlKhur0%3D

    PubMed  CAS  Google Scholar 

  275. M. Mutsch W. Zhou P. Rhodes M. Bopp R. T. Chen T. Linder C. Spyr R. Steffen (2004) ArticleTitleUse of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland N. Engl. J. Med. 350 896–903 Occurrence Handle14985487 Occurrence Handle1:CAS:528:DC%2BD2cXhsFygsbY%3D Occurrence Handle10.1056/NEJMoa030595

    Article  PubMed  CAS  Google Scholar 

  276. J. A. Berzofsky J. D. Ahlers I. M. Belyakov (2001) ArticleTitleStrategies for designing and optimizing new generation vaccines Nat. Rev. Immunol. 1 209–219 Occurrence Handle11905830 Occurrence Handle1:CAS:528:DC%2BD38XmtVSjs70%3D Occurrence Handle10.1038/35105075

    Article  PubMed  CAS  Google Scholar 

  277. M. Diwan P. Elamanchili H. Lane A. Gainer J. Samuel (2003) ArticleTitleBiodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses J. Drug Target. 11 495–507 Occurrence Handle15203918 Occurrence Handle1:CAS:528:DC%2BD2cXjt1Crs78%3D Occurrence Handle10.1080/10611860410001670026

    Article  PubMed  CAS  Google Scholar 

  278. X. Jiao R. Y. Wang Q. Qiu H. J. Alter J. W. Shih (2004) ArticleTitleEnhanced hepatitis C virus NS3 specific Th1 immune responses induced by co-delivery of protein antigen and CpG with cationic liposomes J. Gen. Virol. 85 1545–1553 Occurrence Handle15166438 Occurrence Handle1:CAS:528:DC%2BD2cXltlGhtro%3D Occurrence Handle10.1099/vir.0.79896-0

    Article  PubMed  CAS  Google Scholar 

  279. M. Kerkmann C. L. Costa C. Richter S. Rothenfusser J. Battiany V. Hornung J. Johnson S. Englert T. Ketterer W. Heckl S. Thalhammer S. Endres G. Hartmann (2005) ArticleTitleSpontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon-alpha induction by CpG-A in plasmacytoid dendritic cells J. Biol. Chem. 280 8086–8093 Occurrence Handle15591070 Occurrence Handle1:CAS:528:DC%2BD2MXhs1yitbg%3D Occurrence Handle10.1074/jbc.M410868200

    Article  PubMed  CAS  Google Scholar 

  280. S. Manoj L. A. Babiuk V. Drunen Littel-van den Hurk Particlevan (2004) ArticleTitleApproaches to enhance the efficacy of DNA vaccines Crit. Rev. Clin. Lab. Sci. 41 1–39 Occurrence Handle15077722 Occurrence Handle1:CAS:528:DC%2BD2cXivVCjs7k%3D Occurrence Handle10.1080/10408360490269251

    Article  PubMed  CAS  Google Scholar 

  281. Z. Cui R. J. Mumper (2002) ArticleTitleGenetic immunization using nanoparticles engineered from microemulsion precursor Pharm. Res. 19 939–946 Occurrence Handle12180545 Occurrence Handle1:CAS:528:DC%2BD38Xltl2is7c%3D Occurrence Handle10.1023/A:1016402019380

    Article  PubMed  CAS  Google Scholar 

  282. H. Q. Mao K. Roy V. L. Troung-La K. A. Janes K. Y. Lin Y. Wang J. T. August K. W. Leong (2001) ArticleTitleChitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency J. Control. Release 70 399–421 Occurrence Handle11182210 Occurrence Handle1:CAS:528:DC%2BD3MXhtV2murs%3D Occurrence Handle10.1016/S0168-3659(00)00361-8

    Article  PubMed  CAS  Google Scholar 

  283. M. Bivas-Benita T. H. Ottenhoff H. E. Junginger G. Borchard (2005) ArticleTitlePulmonary DNA vaccination: concepts, possibilities and perspectives J. Control. Release 107 1–29 Occurrence Handle16054263 Occurrence Handle1:CAS:528:DC%2BD2MXpvVSgu7g%3D Occurrence Handle10.1016/j.jconrel.2005.05.028

    Article  PubMed  CAS  Google Scholar 

  284. C. P. Locher D. Putnam R. Langer S. A. Witt B. M. Ashlock J. A. Levy (2003) ArticleTitleEnhancement of a human immunodeficiency virus env DNA vaccine using a novel polycationic nanoparticle formulation Immunol. Lett. 90 67–70 Occurrence Handle14687705 Occurrence Handle1:CAS:528:DC%2BD3sXpvVWqu7c%3D Occurrence Handle10.1016/j.imlet.2003.02.001

    Article  PubMed  CAS  Google Scholar 

  285. Z. Cui S. J. Han D. Padinjarae Vangasseri L. Huang (2005) ArticleTitleImmunostimulation mechanism of LPD nanoparticle as a vaccine carrier Mol. Pharmacol. 2 IssueID(1) 22–28 Occurrence Handle1:CAS:528:DC%2BD2cXhtVOjt7vN

    CAS  Google Scholar 

  286. B. Verrier (2005) ArticleTitleTherapeutic vaccination for chronic infectious diseases: lessons from HIV-1 J. Clin. Virol. 34 S9–S12 Occurrence Handle16461232 Occurrence Handle1:CAS:528:DC%2BD28XhtlGmsr0%3D Occurrence Handle10.1016/S1386-6532(05)80003-4

    Article  PubMed  CAS  Google Scholar 

  287. M. L. Michel M. Mancini-Bourgine (2005) ArticleTitleTherapeutic vaccination against chronic hepatitis B virus infection J. Clin. Virol. 34 S108–S114 Occurrence Handle16461209 Occurrence Handle1:CAS:528:DC%2BD28XhtlGnuro%3D Occurrence Handle10.1016/S1386-6532(05)80019-8

    Article  PubMed  CAS  Google Scholar 

  288. World Health Organisation. Diabetes, http://www.who.int/mediacentre/factsheets/fs138/en/index.html, (accessed Nov 15, 2005) part of http://www.who.int (accessed Nov 15, 2005).

  289. S. I. Tanaka T. Yamakawa I. Aoki K. Okuda C. Mobbs (2004) ArticleTitleDaily nasal inoculation with the insulin gene ameliorates diabetes in mice Diabetes Res. Clin. Pract. 63 1–9 Occurrence Handle14693407 Occurrence Handle1:CAS:528:DC%2BD3sXpvF2msbw%3D Occurrence Handle10.1016/j.diabres.2003.07.005

    Article  PubMed  CAS  Google Scholar 

  290. F. Gomez-Perez J. A. Rull (2005) ArticleTitleInsulin therapy: current alternatives Arch. Med. Res. 36 258–72 Occurrence Handle15925016 Occurrence Handle1:CAS:528:DC%2BD2MXks1Cnurg%3D Occurrence Handle10.1016/j.arcmed.2005.03.012

    Article  PubMed  CAS  Google Scholar 

  291. M. Muno-Torres G. Alonso M. P. Raya (2004) ArticleTitleCalcitonin therapy in osteoporosis Treat. Endocrinol. 3 117–132 Occurrence Handle10.2165/00024677-200403020-00006

    Article  Google Scholar 

  292. C. Prego M. Garcia D. Torres M. J. Alonso (2005) ArticleTitleTransmucosal macromolecular drug delivery J. Control. Release 101 151–162 Occurrence Handle15588901 Occurrence Handle1:CAS:528:DC%2BD2cXhtVKgu7bJ Occurrence Handle10.1016/j.jconrel.2004.07.030

    Article  PubMed  CAS  Google Scholar 

  293. Y. Cao L. Lam (2002) ArticleTitleProjections for insulin treatment for diabetics Drugs Today 38 419–427 Occurrence Handle1:CAS:528:DC%2BD38XlvVKnurs%3D Occurrence Handle10.1358/dot.2002.38.6.678349 Occurrence Handle12532178

    Article  CAS  PubMed  Google Scholar 

  294. M. Saffran B. Pansky G. Colin Budd F. E Williams (1997) ArticleTitleInsulin and the gastrointestinal tract J. Control. Release 46 89–98 Occurrence Handle1:CAS:528:DyaK2sXhtlyhsLo%3D Occurrence Handle10.1016/S0168-3659(96)01578-7

    Article  CAS  Google Scholar 

  295. G. Dapergolas G. Gregoriadis (1976) ArticleTitleHypoglycemic effect of liposome-entrapped insulin administered intragastrically into rats Lancet 2 824–827 Occurrence Handle61498 Occurrence Handle1:CAS:528:DyaE2sXkvV0%3D Occurrence Handle10.1016/S0140-6736(76)91209-5

    Article  PubMed  CAS  Google Scholar 

  296. H. M. Patel B. E. Ryman (1976) ArticleTitleOral administration if insulin by encapsulation in liposomes FEBS Lett. 62 60–63 Occurrence Handle129340 Occurrence Handle1:CAS:528:DyaE28XhtlSks74%3D Occurrence Handle10.1016/0014-5793(76)80016-6

    Article  PubMed  CAS  Google Scholar 

  297. J. F. Woodley (1985) ArticleTitleLiposomes for oral administration of drugs Crit. Rev. Ther. Drug Carr. Syst. 2 1–18 Occurrence Handle1:CAS:528:DyaL28XhtFGqsrw%3D

    CAS  Google Scholar 

  298. C. Damgé C. Michel M. Aprahamian P. Couvreur (1988) ArticleTitleNew approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier Diabetes 37 246–251 Occurrence Handle3292320

    PubMed  Google Scholar 

  299. R. S. Spangler (1990) ArticleTitleInsulin administration via liposomes Diabetes Care 13 911–922 Occurrence Handle2226109 Occurrence Handle1:STN:280:DyaK3M%2FjtV2jtA%3D%3D

    PubMed  CAS  Google Scholar 

  300. G. P. Carino E. Mathiowitz (1999) ArticleTitleOral insulin delivery Adv. Drug Deliv. Rev. 35 249–257 Occurrence Handle10837700 Occurrence Handle1:CAS:528:DyaK1MXksFehuw%3D%3D Occurrence Handle10.1016/S0169-409X(98)00075-1

    Article  PubMed  CAS  Google Scholar 

  301. C. Vauthier M. Seiller C. Weingarten P. Couvreur (1999) ArticleTitleContribution to the development of oral dosage form for insulin delivery STP Pharm. Sci. 9 391–396 Occurrence Handle1:CAS:528:DC%2BD3cXjsFyqug%3D%3D

    CAS  Google Scholar 

  302. M. A. Kisel L. N. Kulik I. S. Tsybovsky A. P. Vlasov M. S. Vorob'yov E. A. Kholodava Z. V. Zabarovskaca (2001) ArticleTitleLiposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat Int. J. Pharm. 216 105–114 Occurrence Handle11274812 Occurrence Handle1:CAS:528:DC%2BD3MXitFyru7k%3D Occurrence Handle10.1016/S0378-5173(01)00579-8

    Article  PubMed  CAS  Google Scholar 

  303. P. Couvreur G. Barratt E. Fattal P. Legrand C. Vauthier (2002) ArticleTitleNanocapsule technology: a review Crit. Rev. Ther. Drug Carr. Syst. 19 99–134 Occurrence Handle1:CAS:528:DC%2BD38XntFSksbg%3D Occurrence Handle10.1615/CritRevTherDrugCarrierSyst.v19.i2.10

    Article  CAS  Google Scholar 

  304. S. Watnasirichaikul T. Rades I. G. Tucker N. W. Davies (2002) ArticleTitleIn-vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsion J. Pharm. Pharmacol. 54 473–480 Occurrence Handle11999123 Occurrence Handle1:CAS:528:DC%2BD38XjtlWgur8%3D Occurrence Handle10.1211/0022357021778736

    Article  PubMed  CAS  Google Scholar 

  305. K. Katayama Y. Kato H. Onishi T. Nagai Y. Machida (2003) ArticleTitleDouble liposomes: hypoglycemic effects of liposomal insulin on normal rats Drug Dev. Ind. Pharm. 29 725–731 Occurrence Handle12906329 Occurrence Handle1:CAS:528:DC%2BD3sXltlGmtbw%3D Occurrence Handle10.1081/DDC-120021771

    Article  PubMed  CAS  Google Scholar 

  306. N. Csaba L. Gonzalez A. Sanchez M. J. Alonso (2004) ArticleTitleDesign and characterisation of new nanoparticulate polymer blends for drug delivery J. Biomater. Sci. Polym. Ed. 15 1137–1151 Occurrence Handle15503631 Occurrence Handle1:CAS:528:DC%2BD2cXptFahurw%3D Occurrence Handle10.1163/1568562041753098

    Article  PubMed  CAS  Google Scholar 

  307. M. Simon M. Wittmar T. Kissel T. Linn (2005) ArticleTitleInsulin containing nanocomplexes formed by self-assembly from biodegradable amine-modified poly(vinyl alcohol)-graft-poly(l-lactide): bioavailability and nasal tolerability in rats Pharm. Res. 22 1879–1886 Occurrence Handle16132341 Occurrence Handle1:CAS:528:DC%2BD2MXhtFChs7bM Occurrence Handle10.1007/s11095-005-7676-z

    Article  PubMed  CAS  Google Scholar 

  308. S. Mao O. Germerhaus D. Fischer T. Linn R. Schnepf T. Kissel (2005) ArticleTitleUptake and transport of PEG-graft-trimethyl-chitosan copolymer–insulin nanocomplexes by epithelias cells Pharm. Res. 22 2058–2068 Occurrence Handle16170693 Occurrence Handle1:CAS:528:DC%2BD2MXhtlemtbnM Occurrence Handle10.1007/s11095-005-8175-y

    Article  PubMed  CAS  Google Scholar 

  309. M. Garcia-Fuentes D. Torres M. J. Alonso (2005) ArticleTitleNew surface modified lipid nanoparticles as delivery vehicle for salmon calcitonin Int. J. Pharm. 296 122–132 Occurrence Handle15885464 Occurrence Handle1:CAS:528:DC%2BD2MXktVais74%3D Occurrence Handle10.1016/j.ijpharm.2004.12.030

    Article  PubMed  CAS  Google Scholar 

  310. N. Zhang Q. N. Ping G. H. Huang W. F. Xu (2005) ArticleTitleInvestigation of lectin-modified insulin liposomes as carriers for oral administration Int. J. Pharm. 294 247–259 Occurrence Handle15814248 Occurrence Handle1:CAS:528:DC%2BD2MXjt1agsrs%3D Occurrence Handle10.1016/j.ijpharm.2005.01.018

    Article  PubMed  CAS  Google Scholar 

  311. M. Aprahamian C. Michel W. Humbert J. P. Devissaguet C. Damgé (1987) ArticleTitleTransmucosal passage of poly(alkylcyanoacrylate) nanocapsules as a new drug carrier in the small intestine Biol. Cell 61 69–76 Occurrence Handle2833966 Occurrence Handle1:CAS:528:DyaL1cXhsFKgtL0%3D

    PubMed  CAS  Google Scholar 

  312. H. Pinto-Alphandary M. Aboubakar D. Jaillard P. Couvreur C. Vauthier (2003) ArticleTitleVisualization of insulin-loaded nanocapsules: in vitro and in vivo studies after oral administration to rats Pharm. Res. 20 1071–1084 Occurrence Handle12880294 Occurrence Handle1:CAS:528:DC%2BD3sXkvFSksr4%3D Occurrence Handle10.1023/A:1024470508758

    Article  PubMed  CAS  Google Scholar 

  313. A. T. Florence (2004) ArticleTitleIssues in oral nanoparticle drug carrier uptake and targeting J. Drug Target. 12 65–70 Occurrence Handle15203899 Occurrence Handle1:CAS:528:DC%2BD2cXktVCqtbo%3D Occurrence Handle10.1080/10611860410001693706

    Article  PubMed  CAS  Google Scholar 

  314. P. Couvreur V. Lenaerts B. Kante M. Roland P. Speiser (1980) ArticleTitleOral and parenteral administration of insulin associated to hydrolysable nanoparticles Acta Pharm. Technol. 26 220

    Google Scholar 

  315. C. Damgé H. Vranckx P. Balschmidt P. Couvreur (1997) ArticleTitlePoly(alkyl cyanoacrylate) nanospheres for oral administration of insulin J. Pharm. Sci. 86 1403–1409 Occurrence Handle9423155 Occurrence Handle10.1021/js970124i

    Article  PubMed  Google Scholar 

  316. M. S. Mesiha M. B. Sidhom B. Fasipe (2005) ArticleTitleOral and subcutaneous absorption of insulin poly(isobutylcyanoacrylate) nanoparticles Int. J. Pharm. 288 289–293 Occurrence Handle15620869 Occurrence Handle1:CAS:528:DC%2BD2cXhtFGhurvO Occurrence Handle10.1016/j.ijpharm.2004.10.003

    Article  PubMed  CAS  Google Scholar 

  317. C. Damgé D. Hillaire-buys R. Puech A. Hilozel C. Michel G. Ribes (1995) ArticleTitleEffect of orally administered insulin nanocapsules in normal and diabetic rats Diab. Nutr. Metab. 8 3–9

    Google Scholar 

  318. P. J. Lowe C. S. Temple (1994) ArticleTitleCalcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats J. Pharm. Pharmacol. 46 547–552 Occurrence Handle7996380 Occurrence Handle1:CAS:528:DyaK2cXlsVWntLs%3D

    PubMed  CAS  Google Scholar 

  319. M. Aboubakar P. Couvreur H. Pinto-Alphandary B. Gouritin B. Lacour R. Farinotti F. Puisieux C. Vauthier (2000) ArticleTitleInsulin-loaded nanocapsules for oral administration; in vitro and in vivo investigation Drug Dev. Res. 49 109–117 Occurrence Handle1:CAS:528:DC%2BD3cXislKis7g%3D Occurrence Handle10.1002/(SICI)1098-2299(200002)49:2<109::AID-DDR4>3.0.CO;2-#

    Article  CAS  Google Scholar 

  320. F. Cournarie D. Auchère D. Chevenne B. Lacour M. Seiller C. Vauthier (2002) ArticleTitleAbsorption and efficiency of insulin after oral administration of insulin-loaded nanocapsules in diabetic rats Int. J. Pharm. 242 325–328 Occurrence Handle12176272 Occurrence Handle1:CAS:528:DC%2BD38Xmt1ynsb8%3D Occurrence Handle10.1016/S0378-5173(02)00175-8

    Article  PubMed  CAS  Google Scholar 

  321. G. P. Carino J. S. Jacob E. Mathiowitz (2000) ArticleTitleNanosphere based oral insulin delivery J. Control. Release 65 261–269 Occurrence Handle10699286 Occurrence Handle1:CAS:528:DC%2BD3cXhtl2qsL0%3D Occurrence Handle10.1016/S0168-3659(99)00247-3

    Article  PubMed  CAS  Google Scholar 

  322. S. Sakuma M. Hayashi M. Akashi (2001) ArticleTitleDesign of nanoparticles composed of graft copolymers for oral peptide delivery Adv. Drug Deliv. Rev. 47 21–37 Occurrence Handle11251243 Occurrence Handle1:CAS:528:DC%2BD3MXhvVajsro%3D Occurrence Handle10.1016/S0169-409X(00)00119-8

    Article  PubMed  CAS  Google Scholar 

  323. C. O. Sullivan C. Birkinshaw (2004) ArticleTitleIn vitro degradation of insulin-loaded poly(n-butylcyanoacrylate) nanoparticles Biomaterials 25 4375–4382 Occurrence Handle15046928 Occurrence Handle1:CAS:528:DC%2BD2cXitlWqt7w%3D Occurrence Handle10.1016/j.biomaterials.2003.11.001

    Article  PubMed  CAS  Google Scholar 

  324. A. Vila A. Sanchez M. Tobio P. Calvo M. J. Alonso (2002) ArticleTitleDesign of biodegradable particles for protein delivery J. Control. Release 78 15–24 Occurrence Handle11772445 Occurrence Handle1:CAS:528:DC%2BD3MXptlaisb8%3D Occurrence Handle10.1016/S0168-3659(01)00486-2

    Article  PubMed  CAS  Google Scholar 

  325. A. M. Hillery P. U. Jani A. T. Florence (1994) ArticleTitleComparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles J. Drug Target. 2 151–156 Occurrence Handle8069593 Occurrence Handle1:STN:280:DyaK2czkvVygsg%3D%3D

    PubMed  CAS  Google Scholar 

  326. E. Mathiowitz J. S. Jacob Y. S. Jong G. P. Carino D. E. Chickering P. Chaturvedi C. A. Santos K. Vijayaraghavan S. Montgomery S. Bassett C. Morrell (1997) ArticleTitleBiologically erodable microspheres as potential oral drug delivery systems Nature 386 410–414 Occurrence Handle9121559 Occurrence Handle1:CAS:528:DyaK2sXit1Wrt7s%3D Occurrence Handle10.1038/386410a0

    Article  PubMed  CAS  Google Scholar 

  327. F. Delie (1998) ArticleTitleEvaluation of nano- and microparticle uptake by the gastrointestinal tract Adv. Drug Deliv. Rev. 34 221–233 Occurrence Handle10837679 Occurrence Handle1:CAS:528:DyaK1cXnsFWlt7w%3D Occurrence Handle10.1016/S0169-409X(98)00041-6

    Article  PubMed  CAS  Google Scholar 

  328. L. Behrens A. I. Pena ParticleVila M. J. Alonso T. Kissel (2002) ArticleTitleComparative uptake studies of bioadhesive and non bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport Pharm. Res. 19 1185–1193 Occurrence Handle12240945 Occurrence Handle1:CAS:528:DC%2BD38XmtlGgs7g%3D Occurrence Handle10.1023/A:1019854327540

    Article  PubMed  CAS  Google Scholar 

  329. Z. Degim N. Unal D. Essiz U. Abbasoglu (2004) ArticleTitleThe effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer Life Sci. 75 2819–2827 Occurrence Handle15464833 Occurrence Handle1:CAS:528:DC%2BD2cXotFCmur4%3D Occurrence Handle10.1016/j.lfs.2004.05.027

    Article  PubMed  CAS  Google Scholar 

  330. G. Ponchel J. Irache (1998) ArticleTitleSpecific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract Adv. Drug Deliv. Rev. 34 191–219 Occurrence Handle10837678 Occurrence Handle1:CAS:528:DyaK1cXnsFWlt78%3D Occurrence Handle10.1016/S0169-409X(98)00040-4

    Article  PubMed  CAS  Google Scholar 

  331. S. P. Clissold A. Fitton P. Chrisp (1991) ArticleTitleIntranasal salmon calcitonin. A review of its pharmacological properties and potential utility in metabolic bone disorders associated with aging Drugs Aging 1 405–423 Occurrence Handle1794028 Occurrence Handle1:STN:280:DyaK387ntlCmsg%3D%3D

    PubMed  CAS  Google Scholar 

  332. S. Turker E. Onur Y. Ozer (2004) ArticleTitleNasal route and drug delivery systems Pharm. World Sci. 26 137–142 Occurrence Handle15230360 Occurrence Handle10.1023/B:PHAR.0000026823.82950.ff

    Article  PubMed  Google Scholar 

  333. R. Fernandez-Urrusuno P. Calvo C. Rumunan-Lopez J. L. Vila-Lato M. J. Alonso (1999) ArticleTitleEnhancement of nasal absorption of insulin using chitosan nanoparticles Pharm. Res. 16 1576–1581 Occurrence Handle10554100 Occurrence Handle1:CAS:528:DyaK1MXntVOhur4%3D Occurrence Handle10.1023/A:1018908705446

    Article  PubMed  CAS  Google Scholar 

  334. A. Vila H. Gill O. McCallion M. J. Alonso (2004) ArticleTitleTransport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density J. Control. Release 98 231–244 Occurrence Handle15262415 Occurrence Handle1:CAS:528:DC%2BD2cXlslGis7Y%3D Occurrence Handle10.1016/j.jconrel.2004.04.026

    Article  PubMed  CAS  Google Scholar 

  335. M. Simon M. Wittmar T. Kissel T. Linn (2005) ArticleTitleInsulin containing nanocomplexes formed by self-assembly from biodegradable amine-modified poly(vinyl alcohol)-graft-poly(l-lactide): bioavailability and nasal tolerability in rats Pharm. Res. 22 1879–1886 Occurrence Handle16132341 Occurrence Handle1:CAS:528:DC%2BD2MXhtFChs7bM Occurrence Handle10.1007/s11095-005-7676-z

    Article  PubMed  CAS  Google Scholar 

  336. C. Vermehren, S. Frokjaer, T. Aurstad, and J. Hansen. Lung surfactant as a drug delivery system. Int. J. Pharm. 307:89–92 (2006).

    Google Scholar 

  337. Y. Li A. K. Mitra (1996) ArticleTitleEffects of phospholipid chain length, concentration, charge and vesicle size on pulmonary insulin absorption Pharm. Res. 13 76–79 Occurrence Handle8668683 Occurrence Handle1:CAS:528:DyaK28XhtFajsr8%3D Occurrence Handle10.1023/A:1016029317299

    Article  PubMed  CAS  Google Scholar 

  338. J. Blanchard J. Coleman C. D'Abreu Hayling R. Ghaderi B. Haeberlin J. Hart S. Jensen R. Malcolmson S. Mittelman L. M. Nagao S. Sekulic C. Snodgrass-Pilla M. Sundahl G. Thompson R. Wolff (2004) ArticleTitleForeign particles testing in orally inhaled and nasal drug products Pharm. Res. 21 2137–2147 Occurrence Handle15648243 Occurrence Handle1:CAS:528:DC%2BD2MXjslOqsg%3D%3D Occurrence Handle10.1007/s11095-004-7665-7

    Article  PubMed  CAS  Google Scholar 

  339. G. L. Wilson E. H. Leiter (1990) ArticleTitleStreptozotocin interactions with pancreatic beta cells and the induction of insulin-dependent diabetes Curr. Top. Microbiol. Immunol. 156 27–54 Occurrence Handle2143132 Occurrence Handle1:STN:280:DyaK3czjs1eqtQ%3D%3D

    PubMed  CAS  Google Scholar 

  340. O. Blondel B. Portha (1989) ArticleTitleEarly appearance of in vivo insulin resistance in adult streptozotocin-injected rats Diab. Metab. 15 382–387 Occurrence Handle1:CAS:528:DyaK3MXkt1Oh

    CAS  Google Scholar 

  341. J. P. Mordes R. Cortell E. P. Clanjenhorn A. A. Rossini D. L. Greiner (2004) ArticleTitleRat models of type 1 diabetes: genetics, environment, and autoimmunity ILAR J. 45 278–291 Occurrence Handle15229375 Occurrence Handle1:CAS:528:DC%2BD2cXkvVyjsro%3D

    PubMed  CAS  Google Scholar 

  342. N. Ubrich C. Schmidt R. Bodmeier M. Hoffman P. Maincent (2005) ArticleTitleOral evaluation in rabbits of cyclosporin-loaded Eudragit RS and RL nanoparticles Int. J. Pharm. 2888 168–175

    Google Scholar 

  343. J. K. Milani U. Pleyer A. Dukes H. J. Chou S. Lutz D. Ruckert K. H. Schmidt B. J. Mondino (1993) ArticleTitleProlongation of corneal allograft survival with liposome-encapsulated cyclosporin in the rat eye Ophthalmology 100 890–896 Occurrence Handle8510902 Occurrence Handle1:STN:280:DyaK3s3ovVeltA%3D%3D

    PubMed  CAS  Google Scholar 

  344. A. M. Campos ParticleDe A. Sanchez M. J. Alonso (2001) ArticleTitleChitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A Int. J. Pharm. 224 159–168 Occurrence Handle11472825 Occurrence Handle10.1016/S0378-5173(01)00760-8

    Article  PubMed  Google Scholar 

  345. F. Lallemand O. Felt-Baeyens K. Bessenghir F. Behar-Cohen R. Gurny (2003) ArticleTitleCyclosporin A delivery to the eye: a pharmaceutical challenge Eur. J. Pharm. Biopharm. 56 307–318 Occurrence Handle14602172 Occurrence Handle1:CAS:528:DC%2BD3sXos12qtb0%3D Occurrence Handle10.1016/S0939-6411(03)00138-3

    Article  PubMed  CAS  Google Scholar 

  346. M. G. Qaddoumi H. Ueda J. Yang J. Dvada V. Labhasetwar V. H. Lee (2004) ArticleTitleThe characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers Pharm. Res. 21 641–648 Occurrence Handle15139521 Occurrence Handle1:CAS:528:DC%2BD2cXjsVWqs7s%3D Occurrence Handle10.1023/B:PHAM.0000022411.47059.76

    Article  PubMed  CAS  Google Scholar 

  347. M. Schwartz (2001) ArticleTitleHarnessing the immune system for neuroprotection: therapeutic vaccines for acute and chronic neurodegenerative disorders Cell Mol. Neurobiol. 21 617–627 Occurrence Handle12043837 Occurrence Handle1:CAS:528:DC%2BD38XkslSktL4%3D Occurrence Handle10.1023/A:1015139718466

    Article  PubMed  CAS  Google Scholar 

  348. J. Schmidt J. M. Metselaar M. H. Wauben K. V. Toyka G. Storm R. Gold (2003) ArticleTitleDrug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis Brain 126 1895–1904 Occurrence Handle12805101 Occurrence Handle10.1093/brain/awg176

    Article  PubMed  Google Scholar 

  349. Y. Kozac ParticleDe K. Andrieux H. Villarroya C. Klein B. Thillaye-Goldenberg M. C. Naud E. Garcia P. Couvreur (2004) ArticleTitleIntraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis Eur. J. Immunol. 34 3702–3712 Occurrence Handle10.1002/eji.200425022 Occurrence Handle1:CAS:528:DC%2BD2cXhtFajtrvE

    Article  CAS  Google Scholar 

  350. M. Schwartz (2004) ArticleTitleVaccination for glaucoma: dream or reality? Brain Res. Bull. 62 481–484 Occurrence Handle15036561 Occurrence Handle1:CAS:528:DC%2BD2cXhsVOlu7o%3D Occurrence Handle10.1016/S0361-9230(03)00073-X

    Article  PubMed  CAS  Google Scholar 

  351. C. Billotey C. Aspord O. Beuf E. Piaggio F. Gazeau M. F. Janier C. Thivolet (2005) ArticleTitleT-cell homing to the pancreas in autoimmune mouse models of diabetes: in vivo MR imaging Radiology 236 579–587 Occurrence Handle15972338

    PubMed  Google Scholar 

  352. C. Vauthier E. Fattal D. Labarre (2004) From polymer chemistry and physicochemistry to nanoparticulate drug carrier design and applications M. J. Yaszemski D. J. Trantolo K. U. Lewamdrowski V. Hasirci D. E. Altobelli D. L. Wise (Eds) Biomaterial Handbook—Advanced Applications of Basic Sciences and Bioengineering Marcel Dekker, Inc. New York, USA 563–598

    Google Scholar 

  353. N. Ammoury H. Fessi J. P. Devissaguet M. Dubrasquet S. Benita (1991) ArticleTitleJejunal absorption, pharmacological activity, and pharmacokinetic evaluation of indomethacin-loaded poly(d,l-lactide) and poly(isobutyl-cyanoacrylate) nanocapsules in rats Pharm. Res. 8 101–105 Occurrence Handle2014197 Occurrence Handle1:CAS:528:DyaK3MXovVGltg%3D%3D Occurrence Handle10.1023/A:1015846810474

    Article  PubMed  CAS  Google Scholar 

  354. F. Fawaz F. Bonini M. Guyot A. M. Lagueny H. Fessi J. P. Devissaguet (1993) ArticleTitleInfluence of poly(dl-lactide) nanocapsules on the biliary clearance and enterohepatic circulation of indomethacin in the rabbit Pharm. Res. 10 750–756 Occurrence Handle8321841 Occurrence Handle1:CAS:528:DyaK3sXkvVSjtLw%3D Occurrence Handle10.1023/A:1018924219540

    Article  PubMed  CAS  Google Scholar 

  355. S. S. Guterres H. Fessi G. Barratt F. Puisieux J. P. Devissaguet (1995) ArticleTitlePoly(d,l-lactide) nanocapsules containing non-steroidal anti-inflammatory drugs: gastrointestinal tolerance following intravenous and oral administration Pharm. Res. 12 1545–1547 Occurrence Handle8584497 Occurrence Handle1:CAS:528:DyaK2MXosleqsrs%3D Occurrence Handle10.1023/A:1016208125979

    Article  PubMed  CAS  Google Scholar 

  356. J. Al-Muhammed A. Y. Ozer M. T. Ercan A. A. Hincal (1996) ArticleTitleIn-vivo studies on dexamethasone sodium phosphate liposomes J. Microencapsul. 13 293–306 Occurrence Handle8860685 Occurrence Handle1:CAS:528:DyaK28XivV2htr8%3D

    PubMed  CAS  Google Scholar 

  357. S. S. Guterres H. Fessi G. Barratt F. Puisieux J. P. Devissaguet (2000) ArticleTitlePoly(rac-lactide) nanocapsules containing diclofenac: protection against muscular damage in rats J. Biomater. Sci., Polym. Ed. 11 1347–1355 Occurrence Handle1:CAS:528:DC%2BD3MXitVKrs7w%3D Occurrence Handle10.1163/156856200744372

    Article  CAS  Google Scholar 

  358. P. Calvo M. J. Alonso J. L. Vila-Jato J. R. Robinson (1996) ArticleTitleImproved ocular bioavailability of indomethacin by novel ocular drug carriers J. Pharm. Pharmacol. 48 1147–1152 Occurrence Handle8961163 Occurrence Handle1:CAS:528:DyaK28XnsFKjtbw%3D

    PubMed  CAS  Google Scholar 

  359. C. Bucolo A. Maltese G. Plugisi R. Pignatello (2002) ArticleTitleEnhanced ocular anti-inflammatory activity of ibuprofen carried by an Eudragit RS100 nanoparticle suspension Ophthalmic Res. 34 319–323 Occurrence Handle12381895 Occurrence Handle1:CAS:528:DC%2BD38XnvV2rs7w%3D Occurrence Handle10.1159/000065608

    Article  PubMed  CAS  Google Scholar 

  360. B. Jiang L. Hu C. Gao J. Shen (2005) ArticleTitleIbuprofen-loaded nanoparticles prepared by a co-precipitation method and their release properties Int. J. Pharm. 304 220–230 Occurrence Handle16182477 Occurrence Handle1:CAS:528:DC%2BD2MXhtFSitLnE Occurrence Handle10.1016/j.ijpharm.2005.08.008

    Article  PubMed  CAS  Google Scholar 

  361. M. J. Heffernan N. Murthy (2005) ArticleTitlePolyketal nanoparticles: a new pH-sensitive biodegradable drug delivery vehicle Bioconjug. Chem. 16 1340–1342 Occurrence Handle16287226 Occurrence Handle1:CAS:528:DC%2BD2MXhtVKhtr7J Occurrence Handle10.1021/bc050176w

    Article  PubMed  CAS  Google Scholar 

  362. S. A. Galindo-Rodriguez F. Puel S. Briancon E. Allemann E. Doelker H. Fessi (2005) ArticleTitleComparative scale-up of three methods for producing ibuprofen-loaded nanoparticles Eur. J. Pharm. Sci. 25 357–367 Occurrence Handle15916889 Occurrence Handle1:CAS:528:DC%2BD2MXlsVCltLk%3D Occurrence Handle10.1016/j.ejps.2005.03.013

    Article  PubMed  CAS  Google Scholar 

  363. E. Merisko-Liversidge G. G. Liversidge E. R. Cooper (2003) ArticleTitleNanosizing: a formulation approach for poorly-water-soluble compounds Eur. J. Pharm. Sci. 18 113–120 Occurrence Handle12594003 Occurrence Handle1:CAS:528:DC%2BD3sXht1Kltrg%3D Occurrence Handle10.1016/S0928-0987(02)00251-8

    Article  PubMed  CAS  Google Scholar 

  364. N. Rasenak H. Hartenhauer B. W. Muller (2003) ArticleTitleMicrocrystals for dissolution rate enhancement of poorly water-soluble drugs Int. J. Pharm. 254 137–145 Occurrence Handle10.1016/S0378-5173(03)00005-X Occurrence Handle1:CAS:528:DC%2BD3sXhsFOrtb8%3D

    Article  CAS  Google Scholar 

  365. A. Eidelman J. M. Weiss J. Lau D. B. Carr (2005) ArticleTitleTopical anaesthetics for dermal instrumentation: a systematic review of randomized, controlled trials Ann. Emerg. Med. 46 343–351 Occurrence Handle16187468 Occurrence Handle10.1016/j.annemergmed.2005.01.028

    Article  PubMed  Google Scholar 

  366. A. Taddio H. K. Soin S. Schuh G. Koren D. Scolnik (2005) ArticleTitleLiposomal lidocaine to improve procedural success rates and reduce procedural pain among children: a randomized controlled trial CMAJ 172 1691–1695 Occurrence Handle15967972

    PubMed  Google Scholar 

  367. E. R. Viscusi (2004) ArticleTitleEmerging techniques in the treatment of postoperative pain Am. J. Health-Syst. Pharm. 61 IssueID (Suppl 1) S11–S14 Occurrence Handle15119756

    PubMed  Google Scholar 

  368. E. R. Vuscusi G. Martin C. T. Hartrick N. Singla G. Manvelian InstitutionalAuthorNameThe EREM Study group (2005) ArticleTitleForty-eight hours of postoperative pain relief after total hip arthroplasty with a novel, extended-release epidural morphine formulation Anesthesiology 102 1014–1022 Occurrence Handle10.1097/00000542-200505000-00022

    Article  Google Scholar 

  369. S. A. Grant (2002) ArticleTitleThe holy grail: long acting local anaesthetics and liposomes Best Pract. Res. Clin. Anaesthesiol. 16 345–352 Occurrence Handle12491562 Occurrence Handle1:CAS:528:DC%2BD38XntVygtL0%3D Occurrence Handle10.1053/bean.2002.0242

    Article  PubMed  CAS  Google Scholar 

  370. S. Mantripragada (2002) ArticleTitleA lipid based depot (DepoFoam technology) for sustained release drug delivery Prog. Lipid Res. 41 392–406 Occurrence Handle12121719 Occurrence Handle1:CAS:528:DC%2BD38Xltleku7g%3D Occurrence Handle10.1016/S0163-7827(02)00004-8

    Article  PubMed  CAS  Google Scholar 

  371. A. Lamprecht J. L. Saumet J. Roux J. P. Benoit (2004) ArticleTitleLipid nanocarriers as drug delivery system for ibuprofen in pain treatment Int. J. Pharm. 278 407–414 Occurrence Handle15196644 Occurrence Handle1:CAS:528:DC%2BD2cXkslKlsrk%3D Occurrence Handle10.1016/j.ijpharm.2004.03.018

    Article  PubMed  CAS  Google Scholar 

  372. D. Betbeder S. Sperandio J. P. Latapie J. Nadai ParticleDe A. Etienn J. M. Zajac B. Frances (2000) ArticleTitleBiovector™ nanoparticles improve antinociceptive efficacy of nasal morphine Pharm. Res. 17 743–748 Occurrence Handle10955851 Occurrence Handle1:CAS:528:DC%2BD3cXlvVCgt78%3D Occurrence Handle10.1023/A:1007594602449

    Article  PubMed  CAS  Google Scholar 

  373. A. M. Wolka J. D. Huber T. P. Davis (2003) ArticleTitlePain and the blood–brain barrier: obstacles to drug delivery Adv. Drug Deliv. Rev. 55 987–1006 Occurrence Handle12935941 Occurrence Handle1:CAS:528:DC%2BD3sXmsVKisbY%3D Occurrence Handle10.1016/S0169-409X(03)00100-5

    Article  PubMed  CAS  Google Scholar 

  374. W. M. Pardridge (1999) ArticleTitleVector-mediated drug delivery to the brain Adv. Drug Deliv. Rev. 36 299–321 Occurrence Handle10837722 Occurrence Handle1:CAS:528:DyaK1MXhvVCnsrs%3D Occurrence Handle10.1016/S0169-409X(98)00087-8

    Article  PubMed  CAS  Google Scholar 

  375. J. C. Olivier (2005) ArticleTitleDrug transport to brain with targeted nanoparticles NeuroRx 2 108–119 Occurrence Handle15717062 Occurrence Handle10.1602/neurorx.2.1.108

    Article  PubMed  Google Scholar 

  376. W. M. Pardridge (2005) ArticleTitleDrug and gene targeting to the brain via blood–brain barrier receptor-mediated transport systems Int. Congr. Ser. 1277 49–62 Occurrence Handle10.1016/j.ics.2005.02.011 Occurrence Handle1:CAS:528:DC%2BD1cXhvVOhtb0%3D

    Article  CAS  Google Scholar 

  377. J. Kreuter (2004) ArticleTitleInfluence of the surface properties on nanoparticle-mediated transport of drugs to the brain J. Nanosci. Nanotechnol. 4 484–488 Occurrence Handle15503433 Occurrence Handle1:CAS:528:DC%2BD2cXotVegur0%3D Occurrence Handle10.1166/jnn.2003.077

    Article  PubMed  CAS  Google Scholar 

  378. M. Brandl G. Gregoriadis (1994) ArticleTitleEntrapment of haemoglobin into liposomes by the dehydration–rehydration method: vesicle characterization and in vivo behaviour Biochim. Biophys. Acta 1196 65–75 Occurrence Handle7986812 Occurrence Handle1:CAS:528:DyaK2MXisFaktLs%3D Occurrence Handle10.1016/0005-2736(94)90296-8

    Article  PubMed  CAS  Google Scholar 

  379. H. Sakai H. Y. Masada Horinouchi E. Ikeda K. Sou S. Takeoka M. Suematsu M. Takaori K. Kobayashi E. Tsuchida (2004) ArticleTitlePhysiological capacity of the reticuloendothelial system for the degradation of hemoglobin vesicles (artificial oxygen carriers) after massive intravenous doses by daily repeated infusions for 14 days J. Pharmacol. Exp. Ther. 311 874–884 Occurrence Handle15297471 Occurrence Handle1:CAS:528:DC%2BD2cXhtVKmt7fF Occurrence Handle10.1124/jpet.104.073049

    Article  PubMed  CAS  Google Scholar 

  380. M. Takaori (2005) ArticleTitleApproach to clinical trial considering medical ethics and efficacy for HbV, liposome encapsulated hemoglobin vesicle Artif. Cells Blood Substit. Immobil. Biotechnol. 33 65–73 Occurrence Handle15768566 Occurrence Handle1:CAS:528:DC%2BD2MXislOjsr0%3D

    PubMed  CAS  Google Scholar 

  381. T. M. S. Chang F. D'Agnillo W. P. Yu S. Razack (2000) ArticleTitleTwo future generations of blood substitutes based on polyhemoglobin–SOD–catalase and nanoencapsulation Adv. Drug Deliv. Rev. 40 213–218 Occurrence Handle10837791 Occurrence Handle1:CAS:528:DC%2BD3cXosVahuw%3D%3D Occurrence Handle10.1016/S0169-409X(99)00051-4

    Article  PubMed  CAS  Google Scholar 

  382. A. J. Khopade S. Khopade N. K. Jain (2002) ArticleTitleDevelopment of hemoglobin aquasomes from spherical hydroxyapatite cores precipitated in the presence of half-generation poly(amidoamine) dendrimer Int. J. Pharm. 241 145–154 Occurrence Handle12086730 Occurrence Handle1:CAS:528:DC%2BD38XkslSgs7w%3D Occurrence Handle10.1016/S0378-5173(02)00235-1

    Article  PubMed  CAS  Google Scholar 

  383. C. Chauvierre M. C. Marden C. Vauthier D. Labarre P. Couvreur L. Leclerc (2004) ArticleTitleHeparin coated poly(alkylcyanoacrylate) nanoparticles coupled to hemoglobin: a new oxygen carrier Biomaterials 25 3081–3086 Occurrence Handle14967542 Occurrence Handle1:CAS:528:DC%2BD2cXhtVemtrk%3D Occurrence Handle10.1016/j.biomaterials.2003.09.097

    Article  PubMed  CAS  Google Scholar 

  384. T. M. Chang D. Powanda W. P. Yu (2003) ArticleTitleAnalysis of polyethylene–glycol–polylactide nano-dimension artificial red blood cells maintaining systemic hemoglobin levels and prevention of methemoglobin formation Artif. Cells Blood Substit. Immobil. Biotechnol. 31 231–247 Occurrence Handle12906306 Occurrence Handle1:CAS:528:DC%2BD3sXlsFKjurc%3D Occurrence Handle10.1081/BIO-120023155

    Article  PubMed  CAS  Google Scholar 

  385. H. Sakai Y. Masada H. Onuma S. Takeoka E. Tsuchida (2004) ArticleTitleReduction of methemoglobin via electron transfer from photoreduced flavin: restoration of O2-binding of concentrated hemoglobin solution coencapsulated in phospholipid vesicles Bioconjug. Chem. 15 1037–1045 Occurrence Handle15366957 Occurrence Handle1:CAS:528:DC%2BD2cXmvFChsrk%3D Occurrence Handle10.1021/bc049913z

    Article  PubMed  CAS  Google Scholar 

  386. C. Passirani G. Barratt J. P. Devissageut D. Labarre (1998) ArticleTitleLong-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) Pharm. Res. 15 1046–1050 Occurrence Handle9688058 Occurrence Handle1:CAS:528:DyaK1cXkvVWgtbc%3D Occurrence Handle10.1023/A:1011930127562

    Article  PubMed  CAS  Google Scholar 

  387. T. Flynn C. Wei (2005) ArticleTitleThe pathway to commercialization for nanomedicine Nanomed. Nanotechnol., Biol. Med. 1 47–51 Occurrence Handle1:CAS:528:DC%2BD2MXlvVSru74%3D Occurrence Handle10.1016/j.nano.2004.11.010

    Article  CAS  Google Scholar 

  388. B. Sangro (2005) ArticleTitleRefined tools for the treatment of hepatocellular carcinoma J. Hepatol. 42 629–631 Occurrence Handle15826709 Occurrence Handle10.1016/j.jhep.2005.02.006

    Article  PubMed  Google Scholar 

  389. C. H. Dubin. Drug discovery and delivery: tear down those walls. Drug Delivery Technology. 3#5 (2005). http://www.drugdeliverytech.com/cgi-bin/article.cgi?idArticle=329 (accessed 08/09/2005), part of http://www.drugdeliverytech.com (accessed 08/09/2005).

  390. C. L. Bennett E. A. Calhoun (2004) ArticleTitlePharmacoeconomics of liposomal anthracycline therapy Semin. Oncol. 31 191–195 Occurrence Handle15717744 Occurrence Handle1:CAS:528:DC%2BD2MXhtVynsLs%3D Occurrence Handle10.1053/j.seminoncol.2004.08.008

    Article  PubMed  CAS  Google Scholar 

  391. F. J. Martin and T. Huang. Stealth liposomal technology: current therapies and future directions. Drug Delivery Technology. 3#5 (2005). http://www.drugdeliverytech.com/cgi-bin/article.cgi?idArticle=155 (accessed 08/09/2005), part of http://www.drugdeliverytech.com (accessed 08/09/2005).

  392. http://ClinicalTrials.gov/ct/gui/action/GetStudy (accessed 12/09/2005) part of http://ClinicalTrials.gov (accessed 12/09/2005).

  393. Z. Galanbor S. A. Marashi B. Rajbar (2005) ArticleTitleNanotechnology helps medicine: nanoscale swimmers and their future applications Med. Hypotheses 65 198–199 Occurrence Handle10.1016/j.mehy.2005.01.023

    Article  Google Scholar 

  394. A. Cavalcanti R. A. Freitas (2005) ArticleTitleNanorobotics control design: a collective behavior approach for medicine IEEE Trans. Nanobiosci. 4 133–140 Occurrence Handle10.1109/TNB.2005.850469

    Article  Google Scholar 

  395. T. Kubik K. Bogunia-Kubik M. Sugisaka (2005) ArticleTitleNanotechnology on duty in medical applications Curr. Pharm. Biotechnol. 6 17–33 Occurrence Handle15727553 Occurrence Handle1:CAS:528:DC%2BD2MXhsVWqtbY%3D

    PubMed  CAS  Google Scholar 

  396. M. D. Burke. Drug delivery technology assessment: the eight assessment gates. Drug Delivery Technology. 3#5 (2005). http://www.drugdeliverytech.com/cgi-bin/article.cgi?idArticle=343 (accessed 08/09/2005), part of http://www.drugdeliverytech.com (accessed 08/09/2005).

  397. B. Bastani D. Fernandez (2002) ArticleTitleIntellectual property rights in nanotechnology Thin Solid Films 420–421 472–477 Occurrence Handle10.1016/S0040-6090(02)00843-X

    Article  Google Scholar 

  398. N. Sadrieh. FDA perspective on nanomaterial containing products. Nanobusiness Conference May 2005. http://www.fda.gov/nanotechnology/powerpoint_conversions/May05_files/handout/index.html (accessed 6 September 2005), part of http://www.fda.gov (accessed 6 September 2005).

  399. Nanotechnologies: A Preliminary Risk Analysis on the Basis of a Workshop Organized by the Health and Consumer Protection Directorate General of the European Commission. European Community 2004. http://europa.eu.int/comm/health/ph_risk/events_risk_en.htm (accessed 22 December 2005), part of http://europa.eu.int (accessed 22 December 2005).

  400. P. J. Borm W. Kreyling (2004) ArticleTitleToxicological hazards of inhaled nanoparticles—potential implications for drug delivery J. Nanosci. Nanotechnol. 4 521–531 Occurrence Handle15503438 Occurrence Handle1:CAS:528:DC%2BD2cXotVegurY%3D Occurrence Handle10.1166/jnn.2004.081

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire de Physico-chimie, Pharmacotechnie et Biopharmacie, UMR CNRS 8612, Université de Paris Sud, 5 Rue J.B. Clément, 92 296, Chatenay-Malabry Cedex, France

    Patrick Couvreur & Christine Vauthier

Authors
  1. Patrick Couvreur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christine Vauthier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christine Vauthier.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Couvreur, P., Vauthier, C. Nanotechnology: Intelligent Design to Treat Complex Disease. Pharm Res 23, 1417–1450 (2006). https://doi.org/10.1007/s11095-006-0284-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-006-0284-8

Key Words

Search

Navigation